<SEC-DOCUMENT>0001104659-23-119527.txt : 20231117
<SEC-HEADER>0001104659-23-119527.hdr.sgml : 20231117
<ACCEPTANCE-DATETIME>20231117162027
ACCESSION NUMBER:		0001104659-23-119527
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20231115
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231117
DATE AS OF CHANGE:		20231117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		231419001

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2330755d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:AMEH="http://apollomed.net/20231115">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_AMEH_apollomed.net_20231115 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20231115_20231115 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001083446 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityCentralIndexKey">0001083446</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ameh-20231115.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-11-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-15</xbrli:startDate>
        <xbrli:endDate>2023-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20231115__20231115_zdGEdI6eyg29"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)
of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):&#160;<span id="xdx_90C_edei--DocumentPeriodEndDate_c20231115__20231115_zoc9jwnCjbI9"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 15, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20231115__20231115_z3Tplnt5usJd"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityRegistrantName">APOLLO MEDICAL HOLDINGS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its
Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20231115__20231115_zv528sjakB9j"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--EntityFileNumber_c20231115__20231115_zpESfufiXmRh"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityFileNumber">001-37392</ix:nonNumeric></span></span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20231115__20231115_zWz9z36SOzXb"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityTaxIdentificationNumber">95-4472349</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission </span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_909_edei--EntityAddressAddressLine1_c20231115__20231115_zZnJfKUCRn0d"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityAddressAddressLine1">1668 S. Garfield Avenue</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20231115__20231115_zb1sUF8PuqZ7"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityAddressAddressLine2">2nd Floor</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCityOrTown_c20231115__20231115_zjAq2TryJPf7"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityAddressCityOrTown">Alhambra</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20231115__20231115_z9KuYZg7nARi"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20231115__20231115_zFIEWJPbQGj4"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:EntityAddressPostalZipCode">91801</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<span id="xdx_907_edei--CityAreaCode_c20231115__20231115_zQ9And1ThGD4"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:CityAreaCode">626</ix:nonNumeric></span>) <span id="xdx_90F_edei--LocalPhoneNumber_c20231115__20231115_zWeXm7zII8Y5"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:LocalPhoneNumber">282-0288</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s Telephone Number, Including
Area Code</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 40%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed Since
Last Report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90E_edei--WrittenCommunications_c20231115__20231115_z4MXwUgbjk3i"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_908_edei--SolicitingMaterial_c20231115__20231115_zwp5RtbqUIA1"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementTenderOffer_c20231115__20231115_zF1uqJL1qwr1"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20231115__20231115_z1UpZFHFSuI4"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; width: 25%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; width: 25%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol(s)</span></td>
    <td style="border: Black 1pt solid; padding-top: 1pt; width: 50%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--Security12bTitle_c20231115__20231115_zGCJjd6tmYY"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--TradingSymbol_c20231115__20231115_zGsrImQu6sX6"><ix:nonNumeric contextRef="AsOf2023-11-15" name="dei:TradingSymbol">AMEH</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--SecurityExchangeName_c20231115__20231115_zSaYpXTzDc5g"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Emerging growth company&#160;</span><span style="font-family: Wingdings"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20231115__20231115_zcEvZQdC1oDd"><ix:nonNumeric contextRef="AsOf2023-11-15" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.02</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 15, 2023, the Board of Directors (the &#8220;Board&#8221;)
of Apollo Medical Holdings, Inc. (the &#8220;Company&#8221;) approved and adopted the Apollo Medical Holdings, Inc. Employment Inducement
Award Plan (the &#8220;Inducement Plan&#8221;), pursuant to which the Company may from time to time grant equity-based awards to new
employees as a material inducement to their employment. Awards granted under the Inducement Plan may be in the form of non-qualified
stock options, stock appreciation rights, restricted stock awards, restricted stock units, and other stock-based awards. The Inducement
Plan was adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4) and will be administered by the Compensation
Committee of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A total of 500,000 shares of the Company&#8217;s common stock, par
value $0.001 per share, have been reserved for issuance pursuant to awards granted under the Inducement Plan (subject to adjustment as
provided in the Inducement Plan). Awards under the Inducement Plan may be granted only to employees who satisfy the standards for inducement
grants under Rule 5635(c)(4) of the Nasdaq Listing Rules, and only when the award is an inducement material to such individual&#8217;s
entering into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The above description of the Inducement Plan does not purport to be
complete and is subject to, and qualified in its entirety by, the full text of the Inducement Plan, a copy of which is filed as <a href="tm2330755d1_ex10-1.htm" style="-sec-extract: exhibit">Exhibit
10.1</a> to this Current Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 9.01</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 11%; padding-top: 1.5pt; text-align: center"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%; padding-top: 1.5pt">&#160;</td>
    <td style="width: 88%; padding-top: 1.5pt; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="background-color: #CCECFF">
    <td style="border-top: black 1pt solid; vertical-align: top; padding-top: 1.5pt; text-align: center"><a href="tm2330755d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom; padding-top: 1.5pt">&#160;</td>
    <td style="border-top: black 1pt solid; vertical-align: bottom; padding-top: 1.5pt"><a href="tm2330755d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Apollo Medical Holdings, Inc. Employment Inducement Award Plan.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 1.5pt; text-align: center"><a href="tm2330755d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.2</span></a></td>
    <td style="vertical-align: bottom; padding-top: 1.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 1.5pt"><a href="tm2330755d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Form of Stock Option Agreement (Employment Inducement Award Plan).</span></a></td></tr>
  <tr style="background-color: #CCECFF">
    <td style="vertical-align: top; padding-top: 1.5pt; text-align: center"><a href="tm2330755d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.3</span></a></td>
    <td style="vertical-align: bottom; padding-top: 1.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 1.5pt"><a href="tm2330755d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Form of Restricted Stock Agreement (Employment Inducement Award Plan).</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 1.5pt; text-align: center"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; padding-top: 1.5pt"><span style="font-size: 10pt">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 49.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom"><span style="font-size: 10pt"><b>APOLLO MEDICAL HOLDINGS, INC.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 51%"><span style="font-size: 10pt">Date: November 17, 2023</span></td>
    <td style="vertical-align: bottom; width: 8%"><span style="font-size: 10pt">By: </span></td>
    <td style="vertical-align: top; width: 41%"><span style="font-size: 10pt">/s/ Thomas S. Lam</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Name:<br />
Title:</span></td>
    <td style="border-top: black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt">Thomas S. Lam, M.D., M.P.H.<br />
Co-Chief Executive Officer and President</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFTdsKgkAQ/QL/YdjnKBV88bGlIrIIkeh1yymWdEdmt9sn9ZeNSjQcmNu5KDVRK1raBhmO87KACtuuMQGhxAsyujMKQ683OUgv8Wp9YOPCsP6EmkSDosmm2UnuA/NhPdY5JMlMkMYy5FkG+62K+r8md7E1umBNA8bVsGfq2GIw/B4dKvMiR+17SDoge0tO7Kbx+P5AGicp7OhhnsQ3D0WhVTQZKlIrpnvXx9x9oBYWDbaS5UfpH9EX2qhJFA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2330755d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 10.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>APOLLO
MEDICAL HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>EMPLOYMENT
INDUCEMENT AWARD PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
I.<BR>
Purpose</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
Plan has been established effective as of November 15, 2023, the date of approval of the Plan by the Board. The Plan&rsquo;s purpose is
to enhance the Company&rsquo;s ability to attract and motivate individuals who are expected to make important contributions to the Company
and its Subsidiaries by providing such individuals with equity-based incentive awards as inducements to enter into employment with the
Company or a Subsidiary. The Plan is intended to be exempt from stockholder approval pursuant to Nasdaq Stock Market Rule 5635(c)(4)
as a plan providing exclusively for &ldquo;employment inducement&rdquo; awards (within the meaning of Nasdaq Stock Market Rule 5635(c)(4)).
Capitalized terms used in the Plan are defined in Article&nbsp;XI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
II.<BR>
Eligibility</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Eligible
Individuals are eligible to be granted Awards under the Plan, subject to the limitations described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
III.<BR>
Administration and Delegation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Administration</U>.
The Plan is administered by the Committee. The Board may reserve to itself any of the authority of the Committee or may act as the Administrator
of the Plan for any or all purposes; provided, however, that any action taken by the Board in connection with the administration of the
Plan shall not be deemed approved by the Board unless such actions are approved by a majority of the Independent Directors. Awards under
the Plan will be approved by (a) the Committee, which shall be comprised entirely of Independent Directors, or (b) a majority of the
Company&rsquo;s Independent Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Powers
of the Administrator</U>. The Administrator has authority to determine which Eligible Individuals receive Awards, grant Awards and establish
the terms and conditions of Awards, subject to the conditions and limitations in the Plan. The Administrator also has the authority to
take all actions and make all determinations under the Plan, to interpret the Plan and Award Agreements and to adopt, amend and repeal
Plan administrative rules, guidelines and practices as it deems advisable, including, but not limited to, the adoption of procedures
from time to time intended to ensure that an individual is an Eligible Individual prior to the granting of any Awards to such individual
under the Plan (including, without limitation, a requirement, if any, that such individual certify to the Company prior to the receipt
of an Award under the Plan that he or she has not previously been employed by the Company or any Subsidiary, or if previously employed,
has had a bona fide period of non-employment, and that the grant of Awards under the Plan is an inducement material to his or her agreement
to enter into employment with the Company or any Subsidiary). The Administrator may correct defects and ambiguities, supply omissions
and reconcile inconsistencies in the Plan or any Award Agreement as it deems necessary or appropriate to administer the Plan and any
Awards. The Administrator&rsquo;s determinations under the Plan are in its sole discretion and will be final and binding on all persons
having or claiming any interest in the Plan or any Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
IV.<FONT STYLE="font-weight: normal"><BR>
</FONT>Stock Available for Awards</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Number
of Shares</U>. Subject to adjustment under Article&nbsp;VIII and the terms of this Article&nbsp;IV, the maximum number of Shares that
may be delivered pursuant to Awards under the Plan shall be 500,000 Shares. Shares issued under the Plan may consist of authorized but
unissued Shares, Shares purchased on the open market or treasury Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Share
Recycling</U>. If all or any part of an Award expires, lapses or is forfeited, canceled, surrendered, reacquired, settled in cash or
terminated without the issuance of Shares, the unused Shares covered by the Award will, as applicable, become or again be available for
Awards under the Plan. In addition, Shares delivered (either by actual delivery or attestation) to the Company by a Participant to satisfy
the applicable exercise or purchase price of an Award and/or to satisfy any applicable tax withholding obligation with respect to an
Award (including Shares retained by the Company from the Award) will, as applicable, become or again be available for Awards under the
Plan. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not count against the Share limit
set forth in Section 4.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
V.<BR>
Stock Options and Stock Appreciation Rights</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General</U>.
The Administrator may grant Options or Stock Appreciation Rights to Eligible Individuals subject to the limitations in the Plan. The
Administrator will determine the number of Shares covered by each Option and Stock Appreciation Right and the conditions and limitations
applicable to the exercise of each Option and Stock Appreciation Right. A Stock Appreciation Right will entitle the Participant (or other
person entitled to exercise the Stock Appreciation Right) to receive from the Company upon exercise of the exercisable portion of the
Stock Appreciation Right an amount determined by multiplying the excess, if any, of the Fair Market Value of one Share on the date of
exercise over the exercise price per Share of the Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation
Right is exercised, subject to any limitations of the Plan or that the Administrator may impose, and payable in cash, Shares or a combination
of the two as the Administrator may determine or provide in the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise
Price</U>. The Administrator will establish the exercise price of each Option and Stock Appreciation Right, which exercise price will
not be less than 100% of the Fair Market Value on the Grant Date of the Option or Stock Appreciation Right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Duration</U>.
Each Option or Stock Appreciation Right will be exercisable at such times and as specified in the Award Agreement, provided that the
term of an Option or Stock Appreciation Right will not exceed ten years. Notwithstanding the foregoing and unless determined otherwise
by the Company, in the event that on the last business day of the term of an Option or Stock Appreciation Right (a) the exercise of the
Option or Stock Appreciation Right is prohibited by Applicable Law, as determined by the Company, or (b) Shares may not be purchased
or sold by the applicable Participant due to any Company insider trading policy (including blackout periods) or a &ldquo;lock-up&rdquo;
agreement undertaken in connection with an issuance of securities by the Company, the term of the Option or Stock Appreciation Right
shall be automatically extended until the date that is 30 days after the end of the legal prohibition, black-out period or lock-up agreement,
as determined by the Company; provided, however, in no event shall the extension last beyond the ten year term (or any shorter maximum,
if applicable) of the applicable Option or Stock Appreciation Right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise</U>.
Options and Stock Appreciation Rights may be exercised by delivering to the Company (or its Agent) a written notice of exercise, in a
form the Administrator approves (which may be electronic and provided through an online platform maintained by an Agent), signed by the
person authorized to exercise the Option or Stock Appreciation Right, together with, as applicable, payment in full of the exercise price
for the number of Shares for which an Option is exercised. Unless the Administrator otherwise determines, an Option or Stock Appreciation
Right may not be exercised for a fraction of a Share. The exercise price of an Option may be paid, in the discretion of the Administrator
and as set forth in the applicable Award Agreement: (a) in cash or its equivalent; (b) by tendering (either by actual delivery or attestation)
previously acquired Shares having an aggregate Fair Market Value at the time of exercise equal to the aggregate exercise price; (c) by
a cashless exercise (including by withholding Shares deliverable upon exercise or through a broker-assisted arrangement to the extent
permitted by Applicable Laws); (d) by a combination of the methods described in the foregoing clauses (a), (b) and/or (c); or (e) through
any other method approved by the Administrator in its discretion. As soon as practicable after receipt of the notification of exercise
and full payment of the exercise price, the Company shall cause the appropriate number of Shares to be issued to the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
VI.<BR>
Restricted Stock; Restricted Stock Units</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General</U>.
The Administrator may grant Restricted Stock, or the right to purchase Restricted Stock, to any Eligible Individual, subject to the Company&rsquo;s
right to repurchase all or part of such Shares at their issue price or other stated or formula price from the Participant (or to require
forfeiture of such Shares) if conditions the Administrator specifies in the Award Agreement are not satisfied before the end of the applicable
restriction period or periods that the Administrator establishes for such Award. In addition, the Administrator may grant Restricted
Stock Units to any Eligible Individual, which may be subject to vesting and forfeiture conditions during the applicable restriction period
or periods, as set forth in an Award Agreement. The Administrator will determine and set forth in the Award Agreement the terms and conditions
for each Restricted Stock and Restricted Stock Unit Award, subject to the conditions and limitations contained in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted
Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends</U>.
Participants holding Shares of Restricted Stock will be entitled to all ordinary cash dividends paid with respect to such Shares, provided,
however, that the Administrator may provide in the Award Agreement that payment of any such ordinary cash dividends may deferred and
contingent upon the vesting of the Restricted Stock. In addition, unless the Administrator provides otherwise, if any dividends or distributions
are paid in Shares or other property, other than an ordinary cash dividend, the Shares or other property will be subject to the same
restrictions on transferability and forfeitability as the Shares of Restricted Stock with respect to which they were paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Certificates</U>. The Company may require that the Participant deposit in escrow with the Company (or its designee) any stock certificates
issued in respect of Shares of Restricted Stock, together with a stock power endorsed in blank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted
Stock Units.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Settlement</U>.
The Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as reasonably practicable after the
Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant&rsquo;s election, in a manner intended
to comply with Section&nbsp;409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder
Rights</U>. A Participant will have no rights of a stockholder with respect to Shares subject to any Restricted Stock Unit unless and
until the Shares are delivered in settlement of the Restricted Stock Unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
VII.<BR>
Other Stock-Based Awards; DIVIDEND EQUIVALENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Stock-Based Awards</U>. Other Stock-Based Awards may be granted to Participants, which may include fully vested Shares or Awards that
are valued in whole or in part by reference to, or otherwise based on the Fair Market Value of, Shares, in each case subject to any conditions
and limitations in the Plan. Other Stock-Based Awards may be paid in Shares, cash or other property, or any combination of the foregoing,
as the Administrator determines. Subject to the provisions of the Plan, the Administrator will determine the terms and conditions of
each Other Stock-Based Award, including any purchase price, performance goal(s) (which may be based on the Performance Criteria), transfer
restrictions, and vesting conditions, which will be set forth in the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividend
Equivalents</U>. A grant of Restricted Stock Units or Other Stock-Based Award may provide a Participant with the right to receive Dividend
Equivalents, and no dividends or Dividend Equivalents shall be payable with respect to Options or Stock Appreciation Rights. Dividend
Equivalents may be paid currently or credited to an account for the Participant, settled in cash or Shares and subject to the same restrictions
on transferability and forfeitability as the Award with respect to which the Dividend Equivalents are paid and subject to other terms
and conditions as set forth in the Award Agreement. Except as otherwise determined by the Administrator and set forth in the applicable
Award Agreement, Dividend Equivalents with respect to an Award shall only be paid out to the Participant to the extent that the vesting
conditions applicable to the underlying Award are satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
VIII.<BR>
Adjustments; Change of control</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Equity
Restructurings and Other Corporate Transactions</U>. In the event of any equity restructuring (within the meaning of Financial Accounting
Standards Board Accounting Standards Codification Topic 718, or any successor thereto), such as a stock dividend, stock split, reverse
stock split, spinoff, rights offering, or recapitalization through a large, nonrecurring cash dividend, the Committee shall cause there
to be an equitable adjustment in the number and kind of Shares specified in Section&nbsp;4.1 of the Plan and, with respect to outstanding
Awards, in the number and kind of Shares subject to outstanding Awards and the exercise price or other price of Shares subject to outstanding
Awards, in each case to prevent dilution or enlargement of the rights of Participants. In the event of any other change in corporate
capitalization, or in the event of a merger, consolidation, liquidation, or similar transaction, the Committee may, in its sole discretion,
cause there to be an equitable adjustment as described in the foregoing sentence, to prevent dilution or enlargement of rights; provided,
however, that, unless otherwise determined by the Committee, the number of Shares subject to any Award shall always be rounded down to
a whole number. Moreover, in the event of any such transaction or event, the Committee, in its discretion, may provide in substitution
for any or all outstanding Awards such alternative consideration (including cash) as it, in good faith, may determine to be equitable
in the circumstances, and may require in connection therewith the surrender of all Awards so replaced. Notwithstanding the foregoing,
the Committee shall not make any adjustment pursuant to this Section 8.1 that would (a) cause an Award that is otherwise exempt from
Section 409A to become subject to Section 409A, or (b)&nbsp;cause an Award that is subject to Section 409A to fail to satisfy the requirements
of Section 409A. The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on all Participants
and any other persons claiming under or through any Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change
of Control</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>In
General</U>. The Administrator may specify, either in an Award Agreement or at the time of a Change of Control, whether an outstanding
Award shall become vested and/or payable, in whole or in part, as a result of a Change of Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Options and Stock Appreciation Rights Not Assumed</U>. If, in connection with a Change of Control, any Options and Stock Appreciation
Rights issued under the Plan are not assumed, or if substitute Options and Stock Appreciation Rights are not issued by the successor
or affiliate thereof in the Change of Control transaction, or if the assumed or substituted awards fail to contain similar terms and
conditions as the Award prior to the Change of Control or fail to preserve, to the extent applicable, the benefit to be provided to the
Participant as of the date of the Change of Control, including but not limited to the right of the Participant to receive shares upon
exercise of the Option or Stock Appreciation Right that are registered for sale to the public pursuant to an effective registration statement
filed with the U.S. Securities and Exchange Commission, then (i) each holder of an Option or Stock Appreciation Right that is outstanding
as of the date of the Change of Control who is an employee of the Company or any Subsidiary shall have the right, and (ii) the Administrator,
in its sole discretion, may grant to a holder of an Option or Stock Appreciation Right that is outstanding as of the date of the Change
of Control who is not an employee of the Company or any Subsidiary the right, exercisable by written notice to the Company (or its successor
in the Change of Control transaction) within 30 days after the Change of Control (but not beyond the Option&rsquo;s or Stock Appreciation
Right&rsquo;s expiration date), to receive, in exchange for the surrender of the Option or Stock Appreciation Right, an amount of cash
equal to the excess of the greater of the Fair Market Value of the Shares determined on the Change of Control date or the Fair Market
Value of the Shares on the date of surrender of the Option or Stock Appreciation Right (to the extent vested and not yet exercised) that
is so surrendered over the exercise price of the Award. If the Committee so determines prior to the Change of Control, any such Option
or Stock Appreciation Right that is not exercised or surrendered prior to the end of such 30-day period will be cancelled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Awards</U>. If, in connection with the Change of Control, the Shares issued to a Participant as a result of the accelerated vesting or
payment of Restricted Stock Restricted Stock Units, Other Stock-Based Awards or Dividend Equivalents under this subsection (c) are not
registered for sale to the public pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission,
then each holder of such Shares shall have the right, exercisable by written notice to the Company (or its successor in the Change of
Control transaction) within 30 days after the Change of Control, to receive, in exchange for the surrender of such Shares an amount of
cash equal to the greater of the Fair Market Value of a Share on the Change of Control date or the Fair Market Value of such Share on
the date of surrender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cancellation
Right</U>. The Administrator may, in its discretion and without the consent of Participants, either by the terms of the Award Agreement
applicable to any Award or by resolution adopted prior to the occurrence of the Change of Control, provide that any outstanding Award
(or a portion thereof) shall, upon the occurrence of such Change of Control, be cancelled in exchange for a payment in cash or other
property (including shares of the resulting entity in connection with a Change of Control) in an amount equal to the excess, if any,
of the Fair Market Value of the Shares subject to the Award, over any exercise price related to the Award, which amount may be zero if
the Fair Market Value of a Share on the date of the Change of Control does not exceed the exercise price per Share of the applicable
Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General</U>.
Except as expressly provided in the Plan or the Administrator&rsquo;s action under the Plan, no Participant will have any rights due
to any subdivision or consolidation of Shares of any class, dividend payment, increase or decrease in the number of Shares of any class
or dissolution, liquidation, merger, or consolidation of the Company or other corporation. Except as expressly provided with respect
to an equity restructuring under Section 8.1 or the Administrator&rsquo;s action under the Plan, no issuance by the Company of Shares
of any class, or securities convertible into Shares of any class, will affect, and no adjustment will be made regarding, the number of
Shares subject to an Award or the Award&rsquo;s grant or exercise price. The existence of the Plan, any Award Agreements and the Awards
granted hereunder will not affect or restrict in any way the Company&rsquo;s right or power to make or authorize (i) any adjustment,
recapitalization, reorganization or other change in the Company&rsquo;s capital structure or its business, (ii) any merger, consolidation
dissolution or liquidation of the Company or sale of Company assets or (iii) any sale or issuance of securities, including securities
with rights superior to those of the Shares or securities convertible into or exchangeable for Shares. The Administrator may treat Participants
and Awards (or portions thereof) differently under this Article&nbsp;VIII.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
IX.<BR>
General Provisions Applicable to Awards</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>.
Except as the Administrator may determine or provide in an Award Agreement or otherwise, Awards may not be sold, assigned, transferred,
pledged or otherwise encumbered, either voluntarily or by operation of law, except for certain beneficiary designations, by will or the
laws of descent and distribution, or, subject to the Administrator&rsquo;s consent, pursuant to a domestic relations order, and, during
the life of the Participant, will be exercisable only by the Participant. Any permitted transfer of an Award hereunder shall be without
consideration, except as required by Applicable Law. References to a Participant, to the extent relevant in the context, will include
references to a Participant&rsquo;s authorized transferee that the Administrator specifically approves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Documentation</U>.
Each Award will be evidenced in an Award Agreement, which may be written or electronic, as the Administrator determines. The Award Agreement
will contain the terms and conditions applicable to an Award. Each Award may contain terms and conditions in addition to those set forth
in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Discretion</U>.
Except as the Plan otherwise provides, each Award may be made alone or in addition or in relation to any other Award. The terms of each
Award to a Participant need not be identical, and the Administrator need not treat Participants or Awards (or portions thereof) uniformly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
of Status</U>. The Administrator will determine how a Participant&rsquo;s Disability, death, Retirement or authorized leave of absence
or any other change or purported change in a Participant&rsquo;s employment or other service affects an Award (including whether and
when a termination of employment or other service has occurred) and the extent to which, and the period during which the Participant,
the Participant&rsquo;s legal representative, conservator, guardian or Designated Beneficiary may exercise rights under the Award, if
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding</U>.
To the extent required by Applicable Laws, a Participant shall be required to satisfy, in a manner satisfactory to the Company or Subsidiary,
as applicable, any withholding tax obligations that arise by reason of the exercise of a Stock Option or Stock Appreciation Right, the
vesting of or settlement of Shares under an Award, the payment of cash in settlement of an Award, an election pursuant to Section&nbsp;83(b)
of the Code or otherwise with respect to an Award. The Company and its Subsidiaries shall not be required to issue or deliver Shares,
make any payment, or recognize the transfer or disposition of any Shares, until such withholding tax obligations are satisfied. The Committee
may permit or require these obligations to be satisfied by having the Company withhold a portion of the Shares that otherwise would be
issued or delivered to a Participant upon exercise of a Stock Option or Stock Appreciation Right or upon the vesting or settlement of
an Award, or by tendering Shares previously acquired, in each case having a value (as determined by the Company) equal to the amount
required to be withheld. Any such elections are subject to such conditions or procedures as may be established by the Committee and may
be subject to disapproval by the Committee. In no event will the value of the Shares to be withheld or tendered pursuant to this Section
9.5 to satisfy applicable withholding taxes exceed the amount of taxes required to be withheld based on the maximum statutory tax rates
in the applicable taxing jurisdictions..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Amendment of Award; Repricing</U>. The Administrator may amend, modify or terminate any outstanding Award, including by substituting
another Award of the same or a different type and changing the exercise or settlement date. The Participant&rsquo;s consent to such action
will be required unless (a) the action, taking into account any related action, does not materially and adversely affect the Participant&rsquo;s
rights under the Award, or (b) the change is permitted under Article&nbsp;VIII or pursuant to Section&nbsp;10.6. Notwithstanding the
foregoing or anything in the Plan to the contrary, the Administrator may, without the approval of the stockholders of the Company, (x)
reduce the exercise price per share of outstanding Options or Stock Appreciation Rights or (y) cancel outstanding Options or Stock Appreciation
Rights in exchange for cash, other Awards or Options or Stock Appreciation Rights with an exercise price per share that is less than
the exercise price per share of the original Options or Stock Appreciation Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
on Delivery of Stock</U>. The Company will not be obligated to deliver any Shares under the Plan or remove restrictions from Shares previously
delivered under the Plan until (a)&nbsp;all Award conditions have been met or removed to the Company&rsquo;s satisfaction, (b)&nbsp;as
determined by the Company, all other legal matters regarding the issuance and delivery of such Shares have been satisfied, including
any applicable securities laws and stock exchange or stock market rules and regulations, and (c)&nbsp;the Participant has executed and
delivered to the Company such representations or agreements as the Administrator deems necessary or appropriate to satisfy any Applicable
Laws. The Company&rsquo;s inability to obtain authority from any regulatory body having jurisdiction, which the Administrator determines
is necessary to the lawful issuance and sale of any securities, will relieve the Company of any liability for failing to issue or sell
such Shares as to which such requisite authority has not been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acceleration</U>.
The Administrator may at any time provide that any Award will become immediately vested and fully or partially exercisable, free of some
or all restrictions or conditions, or otherwise fully or partially realizable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cash
Settlement</U>. Without limiting the generality of any other provision of the Plan, the Administrator may provide, in an Award Agreement
or subsequent to the grant of an Award, in its discretion, that any Award may be settled in cash, Shares or a combination thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
X.<BR>
Miscellaneous</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Right to Employment or Other Status</U>. No person will have any claim or right to be granted an Award, and the grant of an Award will
not be construed as giving a Participant the right to continued employment or any other relationship with the Company or any of its Subsidiaries.
The Company and its Subsidiaries expressly reserve the right at any time to dismiss or otherwise terminate their respective relationships
with a Participant free from any liability or claim under the Plan or any Award, except as expressly provided in an Award Agreement or
in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rights as Stockholder; Certificates</U>. Subject to the Award Agreement, no Participant or Designated Beneficiary will have any rights
as a stockholder with respect to any Shares to be distributed under an Award until becoming the record holder of such Shares. Notwithstanding
any other provision of the Plan, unless the Administrator otherwise determines or Applicable Laws require, the Company will not be required
to deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares may be recorded
in the books of the Company (or, as applicable, its transfer agent or stock plan administrator). The Company may place legends on stock
certificates issued under the Plan that the Administrator deems necessary or appropriate to comply with Applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective
Date and Term of Plan</U>. The Plan is effective on the date on which it is adopted by the Board (the &ldquo;<B><I>Effective Date</I></B>&rdquo;)
and will remain in effect until terminated by the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment
of Plan</U>. The Administrator may amend, suspend or terminate the Plan at any time; provided that no amendment, other than (a) as permitted
by the applicable Award Agreement, (b) as provided under Sections 10.6 and 10.15, or (c) an amendment to increase the Share limit set
forth in Section 4.1, may materially and adversely affect any Award outstanding at the time of such amendment without the affected Participant&rsquo;s
consent. No Awards may be granted under the Plan during any suspension period or after the Plan&rsquo;s termination. Awards outstanding
at the time of any Plan suspension or termination will continue to be governed by the Plan and the Award Agreement, as in effect before
such suspension or termination. The Administrator will obtain stockholder approval of any Plan amendment to the extent necessary to comply
with Applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Provisions
for Foreign Participants</U>. The Administrator may modify Awards granted to Participants who are foreign nationals or employed outside
the United States or establish subplans or procedures under the Plan to address differences in laws, rules, regulations or customs of
such foreign jurisdictions with respect to tax, securities, currency, employee benefit or other matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;409A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General</U>.
To the extent that the Administrator determines that any Award granted under the Plan is subject to Section 409A, the Award Agreement
evidencing such Award shall incorporate the terms and conditions required by Section 409A. To the extent applicable, the Plan and the
Award Agreements shall be interpreted in accordance with Section 409A, such that no adverse tax consequences, interest, or penalties
under Section&nbsp;409A apply. Notwithstanding anything in the Plan or any Award Agreement to the contrary, the Administrator may, without
a Participant&rsquo;s consent, amend this Plan or Awards, adopt policies and procedures, or take any other actions (including amendments,
policies, procedures and retroactive actions) as are necessary or appropriate to preserve the intended tax treatment of Awards, including
any such actions intended to (A)&nbsp;exempt this Plan or any Award from Section&nbsp;409A, or (B)&nbsp;comply with Section&nbsp;409A,
including regulations, guidance, compliance programs and other interpretative authority that may be issued after an Award&rsquo;s Grant
Date. The Company makes no representations or warranties as to an Award&rsquo;s tax treatment under Section&nbsp;409A or otherwise. The
Company will have no obligation under this Section&nbsp;10.6 or otherwise to avoid the taxes, penalties or interest under Section&nbsp;409A
with respect to any Award and will have no liability to any Participant or any other person if any Award, compensation or other benefits
under the Plan are determined to constitute noncompliant &ldquo;nonqualified deferred compensation&rdquo; subject to taxes, penalties
or interest under Section&nbsp;409A. Notwithstanding any contrary provision of the Plan or any Award Agreement, any payment of &ldquo;nonqualified
deferred compensation&rdquo; under the Plan that may be made in installments shall be treated as a right to receive a series of separate
and distinct payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Separation
from Service</U>. If an Award is subject to and constitutes &ldquo;nonqualified deferred compensation&rdquo; under Section&nbsp;409A,
any payment or settlement of such Award upon a termination of a Participant&rsquo;s employment or other service relationship will, to
the extent necessary to avoid taxes under Section&nbsp;409A, be made only upon the Participant&rsquo;s &ldquo;separation from service&rdquo;
(within the meaning of Section&nbsp;409A). For purposes of this Plan or any Award Agreement relating to any such payments or benefits,
references to a &ldquo;termination,&rdquo; &ldquo;termination of employment&rdquo; or like terms means a &ldquo;separation from service.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments
to Specified Employees</U>. Notwithstanding any contrary provision in the Plan or any Award Agreement, any payment(s) of &ldquo;nonqualified
deferred compensation&rdquo; required to be made under an Award subject to Section 409A to a &ldquo;specified employee&rdquo; (as defined
under Section&nbsp;409A and as the Administrator determines) due to his or her &ldquo;separation from service&rdquo; will, to the extent
necessary to avoid taxes under Section&nbsp;409A(a)(2)(B)(i) of the Code, be delayed for the six-month period immediately following such
 &ldquo;separation from service&rdquo; (or, if earlier, until the specified employee&rsquo;s death) and will instead be paid (as set forth
in the Award Agreement) on the day immediately following such six-month period or as soon as administratively practicable thereafter
(without interest). Any payments of &ldquo;nonqualified deferred compensation&rdquo; under such Award payable more than six months following
the Participant&rsquo;s &ldquo;separation from service&rdquo; will be paid at the time or times the payments are otherwise scheduled
to be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations
on Liability</U>. Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, other employee or agent
of the Company or any Subsidiary will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for
any claim, loss, liability, or expense incurred in connection with the Plan or any Award, and such individual will not be personally
liable with respect to the Plan because of any contract or other instrument executed in his or her capacity as an Administrator, director,
officer, other employee or agent of the Company or any Subsidiary. The Company will indemnify and hold harmless each director, officer,
other employee and agent of the Company or any Subsidiary that has been or will be granted or delegated any duty or power relating to
the Plan&rsquo;s administration or interpretation, against any cost or expense (including attorneys&rsquo; fees) or liability (including
any sum paid in settlement of a claim with the Administrator&rsquo;s approval) arising from any act or omission concerning this Plan
unless arising from such person&rsquo;s own fraud or bad faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Actions
Required Upon Grant of Award</U>. Following the issuance of any Award under the Plan, the Company shall, in accordance with the listing
requirements of the applicable securities exchange, (a) promptly issue a press release disclosing the material terms of the grant, including
the recipient(s) of the grant and the number of shares involved (and if the disclosure relates to an award to executive officers, or
if the award was individually negotiated, then the disclosure must include the identity of the recipient), and (b) notify the applicable
securities exchange of such grant no later than the earlier to occur of (i) five calendar days after entering into the agreement to issue
the Award or (ii) the date of the public announcement of the Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Data
Privacy</U>. As a condition for receiving any Award, each Participant explicitly and unambiguously consents to the collection, use and
transfer, in electronic or other form, of personal data as described in this section by and among the Company and its Subsidiaries and
affiliates exclusively for implementing, administering and managing the Participant&rsquo;s participation in the Plan. The Company and
its Subsidiaries and affiliates may hold certain personal information about a Participant, including the Participant&rsquo;s name, address
and telephone number; birthdate; social security number, insurance number or other identification number; salary; nationality; job title(s);
any Shares held in the Company or its Subsidiaries and affiliates; and Award details, to implement, manage and administer the Plan and
Awards (the &ldquo;<B><I>Data</I></B>&rdquo;). The Company and its Subsidiaries and affiliates may transfer the Data amongst themselves
as necessary to implement, administer and manage a Participant&rsquo;s participation in the Plan, and the Company and its Subsidiaries
and affiliates may transfer the Data to third parties assisting the Company with Plan implementation, administration and management.
These recipients may be located in the Participant&rsquo;s country, or elsewhere, and the Participant&rsquo;s country may have different
data privacy laws and protections than the recipients&rsquo; country. By accepting an Award, each Participant authorizes such recipients
to receive, possess, use, retain and transfer the Data, in electronic or other form, to implement, administer and manage the Participant&rsquo;s
participation in the Plan, including any required Data transfer to a broker or other third party with whom the Company or the Participant
may elect to deposit any Shares. The Data related to a Participant will be held only as long as necessary to implement, administer, and
manage the Participant&rsquo;s participation in the Plan. A Participant may, at any time, view the Data that the Company and its Subsidiaries
hold regarding such Participant, request additional information about the storage and processing of the Data regarding such Participant,
recommend any necessary corrections to the Data regarding the Participant or refuse or withdraw the consents in this Section 10.9 in
writing, without cost, by contacting the local human resources representative. If the Participant refuses or withdraws the consents in
this Section 10.9, the Company may cancel Participant&rsquo;s ability to participate in the Plan and, in the Administrator&rsquo;s discretion,
the Participant may forfeit any outstanding Awards. For more information on the consequences of refusing or withdrawing consent, Participants
may contact their local human resources representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.10&nbsp;&nbsp;&nbsp;<U>Severability</U>.
If any portion of the Plan or any action taken under it is held illegal or invalid for any reason, the illegality or invalidity will
not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provisions had been
excluded, and the illegal or invalid action will be null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.11&nbsp;&nbsp;&nbsp;<U>Governing
Documents</U>. If any contradiction occurs between the Plan and any Award Agreement or other written agreement between a Participant
and the Company (or any Subsidiary) that the Administrator has approved, the Plan will govern, unless it is expressly specified in such
Award Agreement or other written document that the specific provision of the Plan will not apply. For clarity, the foregoing sentence
shall not limit the applicability of any additive language contained in an Award Agreement or other written agreement which provides
supplemental or additional terms not inconsistent with the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.12&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. The Plan and all Awards will be governed by and interpreted in accordance with the laws of the State of Delaware, disregarding
any state&rsquo;s choice-of-law principles requiring the application of a jurisdiction&rsquo;s laws other than the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.13&nbsp;&nbsp;&nbsp;<U>Clawback
Provisions</U>. All Awards (including, without limitation, any proceeds, gains or other economic benefit actually or constructively received
by a Participant upon any receipt or exercise of any Award or upon the receipt or resale of any Shares underlying the Award) shall be
subject to the provisions of any compensation recovery or clawback policy implemented by the Company, including, without limitation,
any clawback policy adopted to comply with Applicable Laws (including the Dodd-Frank Wall Street Reform and Consumer Protection Act and
the rules or regulations promulgated thereunder) as and to the extent set forth in such clawback policy or the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.14&nbsp;&nbsp;&nbsp;<U>Titles
and Headings</U>. The titles and headings in the Plan are for convenience of reference only and, if any conflict, the Plan&rsquo;s text,
rather than such titles or headings, will control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.15&nbsp;&nbsp;&nbsp;<U>Conformity
to Securities Laws</U>. Participant acknowledges that the Plan is intended to conform to the extent necessary with Applicable Laws. Notwithstanding
anything herein to the contrary, the Plan and all Awards will be administered only in conformance with Applicable Laws. To the extent
Applicable Laws permit, the Plan and all Award Agreements will be deemed amended as necessary to conform to Applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.16&nbsp;&nbsp;&nbsp;<U>Unfunded
Status of Awards.</U> The Plan is intended to be an &ldquo;unfunded&rdquo; plan for incentive compensation. With respect to any payments
not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give the Participant any
rights that are greater than those of a general creditor of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.17&nbsp;&nbsp;&nbsp;<U>Relationship
to Other Benefits</U>. No payment under the Plan will be taken into account in determining any benefits under any pension, retirement,
savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary except as expressly provided
in writing in such other plan or an agreement thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.18&nbsp;&nbsp;&nbsp;<U>Stockholder
Approval Not Required</U>. It is expressly intended that approval of the Company&rsquo;s stockholders not be required as a condition
of the effectiveness of the Plan, and the Plan&rsquo;s provisions shall be interpreted in a manner consistent with such intent for all
purposes. Specifically, Nasdaq Stock Market Rule 5635(c) generally requires stockholder approval for stock option plans or other equity
compensation arrangements adopted by companies whose securities are listed on the Nasdaq Stock Market pursuant to which stock awards
or stock may be acquired by officers, directors, employees or consultants of such companies. Nasdaq Stock Market Rule 5635(c)(4) provides
an exemption in certain circumstances for &ldquo;employment inducement&rdquo; awards (within the meaning of Nasdaq Stock Market Rule
5635(c)(4)). Notwithstanding anything to the contrary herein, Awards under the Plan may only be made to employees who have not previously
been an employee or director of the Company or a parent or Subsidiary, or following a bona fide period of non-employment by the Company
or a parent or Subsidiary, in each case as an inducement material to the employee&rsquo;s entering into employment with the Company or
a Subsidiary. Awards under the Plan will be approved by (y) the Committee, which shall be comprised solely of Independent Directors,
or (z) a majority of the Company&rsquo;s Independent Directors. Accordingly, pursuant to Nasdaq Stock Market Rule 5635(c)(4), the issuance
of Awards and the Shares issuable upon exercise or vesting of such Awards pursuant to the Plan are not subject to the approval of the
Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">ARTICLE
XI.<BR>
Definitions</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
used in the Plan, the following words and phrases will have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Administrator</I></B>&rdquo;
means the Committee, except to the extent that the Board has assumed the authority for administration of the Plan in accordance with
Section 3.1 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>&ldquo;<B>Agent</B></I>&rdquo;
means the brokerage firm, bank or other financial institution, entity or person(s), if any, engaged, retained, appointed or authorized
to act as the agent of the Company or a Participant with regard to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Applicable
Laws</I></B>&rdquo; means the requirements relating to the administration of equity incentive plans under U.S. federal and state securities,
tax and other applicable laws, rules and regulations, the applicable rules of any stock exchange or quotation system on which Shares
are listed or quoted and the applicable laws and rules of any foreign country or other jurisdiction where Awards are granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Award</I></B>&rdquo;
means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock
Units, Dividend Equivalents, or Other Stock-Based Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Award
Agreement</I></B>&rdquo; means a written notice or agreement evidencing an Award, which may be electronic, that contains such terms and
conditions as the Administrator determines, consistent with and subject to the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Board</I></B>&rdquo;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Change
of Control</I></B>&rdquo; means the occurrence of any one of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if more than
fifty percent (50%) of the combined voting power of the continuing or surviving entity&rsquo;s securities outstanding immediately after
such merger, consolidation or other reorganization is owned by Persons who were not stockholders of the Company immediately prior to
such merger, consolidation or other reorganization;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
sale, transfer or other disposition of all or substantially all of the Company&rsquo;s assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
change in the composition of the Board, as a result of which fewer than fifty percent (50%) of the incumbent Directors are Directors
who either (i) had been Directors of the Company on the date twenty-four (24) months prior to the date of the event that may constitute
a Change of Control (the &ldquo;original directors&rdquo;) or (B) were elected, or nominated for election, to the Board with the affirmative
votes of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination
and the Directors whose election or nomination was previously so approved; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
transaction as a result of which any Person is the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented
by the Company&rsquo;s then outstanding voting securities. For purposes of this paragraph (iv), the term &ldquo;Person&rdquo; shall exclude
(A) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a Subsidiary and (B) a corporation
owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common
stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
transaction shall not constitute a Change of Control if its sole purpose is to change the state of the Company&rsquo;s incorporation
or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&rsquo;s securities
immediately before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Notwithstanding
anything herein contained to the contrary, with respect to an Award that is or may be considered deferred compensation subject to Section
409A, the definition of &ldquo;Change of Control&rdquo; herein shall be amended and interpreted in a manner that allows the definition
to satisfy the requirements of a change in control event under Section 409A solely for purposes of complying with the requirements of
Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Code</I></B>&rdquo;
means the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Committee</I></B>&rdquo;
means the Compensation Committee of the Board comprised of two or more Directors, each of whom is intended to qualify as a Non-Employee
Director and Independent Director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.10&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Company</I></B>&rdquo;
means Apollo Medical Holdings, Inc., a Delaware corporation, or any successor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.11&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Designated
Beneficiary</I></B>&rdquo; means the beneficiary or beneficiaries the Participant designates, in a manner the Administrator determines,
to receive amounts due or exercise the Participant&rsquo;s rights if the Participant dies or becomes incapacitated. Without a Participant&rsquo;s
effective designation, &ldquo;Designated Beneficiary&rdquo; will mean the Participant&rsquo;s estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.12&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Director</I></B>&rdquo;
means a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.13&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Disability</I></B>&rdquo;
has the meaning ascribed to the term in Code Section 22(e)(3), as determined by the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.14&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Dividend
Equivalents</I></B>&rdquo; means a right granted to a Participant under the Plan to receive the equivalent value (in cash or Shares)
of dividends paid on Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.15&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Eligible
Individual</I></B>&rdquo; means any prospective Employee who has not previously been an Employee or Director of the Company or any Subsidiary,
or who is commencing employment with the Company or any Subsidiary following a bona fide period of non-employment by the Company or any
Subsidiary, if he or she is granted an Award in connection with his or her commencement of employment with the Company or any Subsidiary
and such grant is an inducement material to his or her entering into employment with the Company or any Subsidiary (within the meaning
of Nasdaq Stock Market Rule IM-5636-1 or any successor rule, if the Company&rsquo;s securities are traded on the Nasdaq Stock Market,
and/or the applicable requirements of any other established stock exchange on which the Company&rsquo;s securities are traded, as applicable,
as such rules and requirements may be amended from time to time).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.16&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Employee</I></B>&rdquo;
means any employee of the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.17&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Exchange
Act</I></B>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.18&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Fair
Market Value</I></B>&rdquo; means the value of one Share on any relevant date, determined under the following rules: (i) the closing
sale price per Share on that date as reported on the Nasdaq Stock Market or such other principal exchange on which Shares are then trading,
if any, or if there are no sales on that date, on the next preceding trading day during which a sale occurred; (ii) if the Shares are
not reported on a principal exchange or national market system, the average of the closing bid and asked prices last quoted on that date
by an established quotation service for over-the-counter securities; or (iii) if neither (i) nor (ii) applies, the value as determined
by the Administrator through the reasonable application of a reasonable valuation method, taking into account all information material
to the value of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.19&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Grant
Date</I></B>&rdquo; means the date specified by the Administrator on which the grant of an Award is to be effective. The Date of Grant
shall not be earlier than the date of the resolution and action therein by the Administrator to grant such Award. In no event shall the
Date of Grant be earlier than the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.20&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Independent
Director</I></B>&rdquo; means a Director of the Company who is not an Employee and who qualifies as &ldquo;independent&rdquo; within
the meaning of Nasdaq Stock Market Rule 5605(a)(2), or any successor rule, if the Company&rsquo;s securities are traded on the Nasdaq
Stock Market, and/or the applicable requirements of any other established stock exchange on which the Company&rsquo;s securities are
traded, as applicable, as such rules and requirements may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.21&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Non-Employee
Director</I></B>&rdquo; means a Director who qualifies as a &ldquo;Non-Employee Director&rdquo; as defined in Rule 16b-3(b)(3) of the
Exchange Act, or any successor definition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.22&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Non-Qualified
Stock Option</I></B>&rdquo; means an Option that does not qualify as and is not an &ldquo;incentive stock option&rdquo; as defined in
Section&nbsp;422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.23&nbsp;&nbsp;&nbsp;
 &ldquo;<B><I>Option</I></B>&rdquo; means an option to purchase Shares. All Options granted under the Plan will be Non-Qualified Stock
Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.24&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Other
Stock-Based Awards</I></B>&rdquo; means cash awards, awards of Shares, and other awards valued wholly or partially by referring to, or
are otherwise based on, Shares or other property awarded to a Participant under Article&nbsp;VII.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.25&nbsp;&nbsp;&nbsp;
 &ldquo;<B><I>Participant</I></B>&rdquo; means an Eligible Individual who has been granted an Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.26&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Performance
Criteria</I></B>&rdquo; means the criteria (and adjustments) that the Administrator may select for an Award to establish performance
goals for a performance period, which may include (but shall not be limited to) the following: (a) revenue; (b) earnings before interest,
taxes, depreciation and amortization, as adjusted (EBITDA as adjusted); (c) income before income taxes and minority interests; (d) operating
income; (e) pre- or after-tax income; (f) average accounts receivable; (g) cash flow; (h) cash flow per share; (i) net earnings; (j)
basic or diluted earnings per share; (k) return on equity; (l) return on assets; (m) return on capital; (n) growth in assets; (o) economic
value added; (p) share price performance; (q) total stockholder return; (r) improvement or attainment of expense levels; (s) market share
or market penetration; or (t) business expansion, and/or acquisitions or divestitures. Such performance goals may be based solely by
reference to the Company&rsquo;s performance or the performance of a Subsidiary, division, business segment or business unit of the Company
or a Subsidiary, or based upon performance relative to performance of other companies or upon comparisons of any of the indicators of
performance relative to performance of other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.27&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Plan</I></B>&rdquo;
means this Apollo Medical Holdings, Inc. Employment Inducement Award Plan, as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.28&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Restricted
Stock</I></B>&rdquo; means Shares awarded to a Participant under Article&nbsp;VI subject to certain vesting conditions and other restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.29&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Restricted
Stock Unit</I></B>&rdquo; means an unfunded, unsecured right to receive, on the applicable settlement date, one Share or an amount in
cash or other consideration determined by the Administrator to be of equal value as of such settlement date awarded to a Participant
under Article&nbsp;VI subject to certain vesting conditions and other restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.30&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Retirement</I></B>&rdquo;
means, unless the Administrator determines otherwise in an Award Agreement, termination of employment from the Company and its Subsidiaries
on or after age 65 with five (5) years of continuous service with the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.31&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Rule
16b-3</I></B>&rdquo; means Rule 16b-3 promulgated under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.32&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Section&nbsp;409A</I></B>&rdquo;
means Section&nbsp;409A of the Code and all regulations, guidance, compliance programs and other interpretative authority thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.33&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Securities
Act</I></B>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.34&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Shares</I></B>&rdquo;
means shares of the Company&rsquo;s common stock, $0.001 par value per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.35&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Stock
Appreciation Right</I></B>&rdquo; means a stock appreciation right granted under Article&nbsp;V.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.36&nbsp;&nbsp;&nbsp;&ldquo;<B><I>Subsidiary</I></B>&rdquo;
means any corporation or other entity in which the Company owns, directly or indirectly, a proprietary interest of more than fifty percent
(50%) by reason of stock ownership or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-weight: normal">[END
OF DOCUMENT]</FONT></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2330755d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT INDUCEMENT AWARD PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>STOCK OPTION GRANT NOTICE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Apollo Medical Holdings, Inc.
(the &ldquo;<U>Company</U>&rdquo;), pursuant to its Employment Inducement Award Plan (the &ldquo;<U>Plan</U>&rdquo;), hereby grants to
the individual listed below (&ldquo;<U>Participant</U>&rdquo;), as an inducement to the Participant&rsquo;s commencement of employment
with the Company or a Subsidiary, an option (the &ldquo;<U>Option</U>&rdquo;) to purchase the number of shares of the Company&rsquo;s
common stock, par value $0.001 (&ldquo;<U>Shares</U>&rdquo;), set forth below for the exercise price per Share set forth below (the &ldquo;<U>Exercise
Price</U>&rdquo;). The Option subject to all of the terms and conditions set forth herein and in the Stock Option Agreement attached hereto
as <U>Exhibit A</U> (the &ldquo;<U>Option Agreement</U>&rdquo;) and the Plan, each of which are incorporated herein by reference. Capitalized
terms used but not defined in this Grant Notice and the Option Agreement shall have the meanings given to such terms in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Participant:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Grant Date:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Total Number of Option
Shares:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Exercise Price:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Vesting Schedule:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Expiration Date:</TD><TD STYLE="text-align: justify">the
tenth anniversary of the Grant Date</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing below, Participant
agrees to be bound by the terms and conditions of the Plan, the Option Agreement and this Grant Notice. Participant has reviewed the Option
Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing
this Grant Notice and fully understands all provisions of this Grant Notice, the Option Agreement and the Plan. Participant hereby agrees
to accept as binding, conclusive and final all decisions or interpretations of the Company and the Committee (as defined in the Plan)
upon any questions arising under the Plan, this Grant Notice or the Option Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the undersigned have executed this Grant Notice effective as of the Grant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>APOLLO MEDICAL HOLDINGS, INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>PARTICIPANT</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;<FONT STYLE="font-size: 10pt"><U></U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; width: 5%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 43%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 43%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO STOCK OPTION GRANT NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>STOCK OPTION AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>1.</B></TD><TD STYLE="text-align: justify"><B>General.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined
Terms</U>. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice, unless
the context clearly indicates otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Incorporation
of Terms of Plan</U>. The Option subject to the terms and conditions of the Plan which are incorporated herein by reference. In the event
of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Grant.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Option</U>. In consideration of Participant&rsquo;s employment with the Company or a Subsidiary and for other good and valuable consideration,
effective as of the Grant Date set forth in the Grant Notice (the &ldquo;<U>Grant Date</U>&rdquo;), the Company grants to Participant
the Option, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article VIII
of the Plan. The Option is a nonqualified stock option, and shall not be treated as an &ldquo;incentive stock option&rdquo; (within the
meaning of Section 422 of the Code).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Consideration
to the Company</U>. In consideration of the grant of the Option by the Company, Participant agrees to render faithful and efficient services
to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ
or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries,
which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever,
with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and
Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price</U>. The exercise price of the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject to adjustment
as provided in Article VIII of the Plan (the &ldquo;<U>Exercise Price</U>&rdquo;). Payment of the Exercise Price shall be made in accordance
with Section 3.2 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Term
of Option</U>. The Option shall terminate on the Expiration Date as specified in the Stock Option Grant Notice, but shall be subject to
earlier termination as provided herein or in the Plan. Upon termination of the Participant&rsquo;s employment or service for any reason,
any vested portion of the Option shall remain exercisable for 90 days thereafter, and any unvested portion of the Option shall be forfeited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Vesting, Exercise, Restrictions, Etc.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Vesting</U>.
Subject to the terms and conditions of the Plan, the Option shall vest and become exercisable at such times as are set forth in the Grant
Notice; provided, however, no portion of the Option that has not become vested at the date of Participant&rsquo;s termination of employment
or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become
vested, except as may be otherwise provided by the Committee or as set forth in a written agreement between the Company and Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Method
of Exercise</U>. Subject to the terms and conditions of this Agreement, the Option, to the extent vested and exercisable, may be exercised,
in whole or in part, by written notice to the Company or its designee, in substantially the form of&nbsp;attached hereto (or in such other
form acceptable to the Company, which may include electronic notice). Such notice shall state the number of Shares with respect to which
the Option is being exercised and shall be signed by the person exercising the Option (which signature may be provided electronically
in a form acceptable to the Company). Payment of the Exercise Price for such Shares shall be made in cash or its equivalent, or in such
other manner as may be approved by the Committee pursuant to the Plan. The Company shall deliver such Shares as soon as practicable after
the notice shall be received, provided, however, that (a) no fractional Shares shall be issued pursuant to this Option, and (b) the Company
may delay issuance of such Shares until completion of any action or obtaining of any consent, which the Company deems necessary under
any Applicable Laws (including, without limitation, state securities or &ldquo;blue sky&rdquo; laws). The Shares as to which the Option
shall have been so exercised shall be registered in the Company&rsquo;s share register in the name of the person so exercising the Option
and shall be delivered as provided above to or upon the written order of the person exercising the Option. In the event the Option shall
be exercised, by any person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person
to exercise the Option. All Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid and
nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>.
The Option shall not be transferable by the Participant otherwise than by will or by the laws of descent and distribution, provided that
the Company may permit the Participant to designate a beneficiary to exercise any vested portion of the Option in the event of the Participant&rsquo;s
death. Except as provided above in this paragraph, the Option shall be exercisable, during the Participant&rsquo;s lifetime, only by the
Participant and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be
subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of
the Option or of any rights granted hereunder contrary to the provisions of this Section&nbsp;3.3, or the levy of any attachment or similar
process upon the Option shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax
Withholding</U>. The Participant acknowledges and agrees that any income or other taxes due from the Participant with respect to the Option
(upon exercise of the Option, the sale of Shares issued pursuant to the Option or otherwise) shall be the Participant&rsquo;s responsibility.
Without limiting the foregoing, the parties agree that to the extent the Company or any Subsidiary is required to withhold any federal,
state, local, foreign or other taxes in connection with the exercise of the Option, then the Company or Subsidiary (as applicable) shall
retain a number of Shares otherwise deliverable hereunder with a value equal to the required withholding (based on the fair market value
of the Shares on the applicable date); provided that in no event shall the value of the Shares retained exceed the minimum amount of taxes
required to be withheld or such other amount that will not result in a negative accounting impact. Notwithstanding the foregoing, (a)
to the extent permitted by the Committee, the Participant may elect, in accordance with procedures adopted by the Company from time to
time, to&nbsp;pay or provide for payment of the required tax withholding, and (b) in the event that the Company or any Subsidiary is required
to withhold taxes at any time other than upon exercise of the Option, the Company may withhold applicable taxes from other compensation
payable to the Participant or require the Participant to make arrangements satisfactory to the Company to provide for such tax withholding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
as Stockholder</U>. The Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until exercise
of the Option and registration of the Shares in the Company&rsquo;s share register in the name of the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Other Provisions.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Administration</U>.
The Committee shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation
and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations
and determinations made by the Committee in good faith shall be final, binding and conclusive upon Participant, the Company and all other
interested persons. No member of the Committee or the Board, or any employee or officer of the Company, shall be personally liable for
any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments
Upon Specified Events</U>. The Committee may accelerate the vesting and exercisability of the Option in such circumstances as it, in its
sole discretion, may determine. In addition, upon the occurrence of certain events relating to the Company&rsquo;s common stock contemplated
by the Plan (including, without limitation, an extraordinary cash dividend on such Shares), the Committee shall make such adjustments
as the Committee deems appropriate to the Option in order to preserve the benefits intended to be made available to Participant under
this Agreement. Participant acknowledges that the Option is subject to adjustment, modification and termination in certain events as provided
in this Agreement and the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of
the Company (or any other person or entity as designated by the Committee) at the Company&rsquo;s principal office, and any notice to
be given to Participant shall be addressed to Participant at Participant&rsquo;s last address reflected on the Company&rsquo;s records.
By a notice given pursuant to this Section 4.3, either party may hereafter designate a different address for notices to be given to that
party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited
(with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Titles
and Headings</U>. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation,
validity, administration, enforcement and performance of the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conformity
to Laws</U>. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions
of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder,
state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be
administered, and the Option is granted and shall be administered only in such a manner as to conform to such laws, rules and regulations.
To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such
laws, rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments,
Suspension and Termination</U>. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified,
suspended or terminated at any time or from time to time by the Committee or the Board; <U>provided</U>, <U>however</U>, that except as
may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect
the Option in any material way without the prior written consent of Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall
inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section
3.3 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Not
a Contract of Employment</U>. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as
an employee or other service provider of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto) constitute the entire agreement of the parties
and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Data
Privacy</U>. In order to administer the Plan, the Company may process personal data about the Participant. Such data includes, but is
not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about
the Participant such as home address and business addresses and other contact information, and any other information that might be deemed
appropriate by the Company to facilitate the administration of the Plan. The Participant hereby gives explicit consent to the Company
to process any such personal data. The Participant also gives explicit consent to the Company to transfer any such personal data outside
the country in which the Participant works or is employed, including, if the Participant is not a U.S. resident, to the United States,
to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Electronic
Delivery</U>. The Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver,
including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual
and quarterly reports, and all other forms of communications (&ldquo;<U>Prospectus Information</U>&rdquo;) in connection with this and
any other Award made or offered under the Plan. The Participant has the right at any time to request that the Company deliver written
copies of any and all Prospectus Information at no charge. The Participant also hereby consents to any and all procedures the Company
has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that
the Company may elect to deliver and agrees that the Participant&rsquo;s electronic response or signature is the same as, and shall have
the same force and effect as, the Participant&rsquo;s manual signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><U>NOTICE OF EXERCISE
OF STOCK OPTION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt">To:</TD>
    <TD STYLE="font-size: 10pt"><B>Apollo Medical Holdings, Inc.</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">I hereby exercise my
Stock Option to purchase _________ shares (the &ldquo;<U>Shares</U>&rdquo;) of the common stock, $0.001 par value, of Apollo Medical Holdings,
Inc. (the &ldquo;<U>Company</U>&rdquo;), at the Exercise Price of $____&nbsp;per Share, pursuant to and subject to the terms of that Stock
Option Grant Notice dated ______________, 20__.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">I understand the nature
of the investment I am making and the financial risks thereof. I am aware that it is my responsibility to have consulted with competent
tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the exercise of the Option
and the purchase and subsequent sale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">I am paying the Exercise
Price for the Shares as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 50%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Participant (signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Print Name</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>Date</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 279pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 279pt; background-color: white"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">\</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 279pt; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>tm2330755d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT INDUCEMENT AWARD PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RESTRICTED STOCK GRANT NOTICE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Apollo Medical Holdings, Inc.
(the &ldquo;<U>Company</U>&rdquo;), pursuant to its Employment Inducement Award Plan (the &ldquo;<U>Plan</U>&rdquo;), hereby grants to
the individual listed below (&ldquo;<U>Participant</U>&rdquo;), as an inducement to the Participant&rsquo;s commencement of employment
with the Company or a Subsidiary, the number of shares of the Company&rsquo;s common stock, par value $0.001, set forth below (individually
and collectively referred to as the &ldquo;<U>Restricted Shares</U>&rdquo;). The Restricted Shares are subject to all of the terms and
conditions set forth herein and in the Restricted Stock Agreement attached hereto as <U>Exhibit A</U> (the &ldquo;<U>Restricted Stock
Agreement</U>&rdquo;) and the Plan, each of which are incorporated herein by reference. Capitalized terms used but not defined in this
Grant Notice and the Restricted Stock Agreement shall have the meanings given to such terms in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Participant:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Grant Date:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Total Number of Restricted
Shares:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 3in">Vesting Schedule:</TD><TD STYLE="text-align: justify">_________________________</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing below, Participant
agrees to be bound by the terms and conditions of the Plan, the Restricted Stock Agreement and this Grant Notice. Participant has reviewed
the Restricted Stock Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel
prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Restricted Stock Agreement and the
Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company and the Committee
(as defined in the Plan) upon any questions arising under the Plan, this Grant Notice or the Restricted Stock Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the undersigned have executed this Grant Notice effective as of the Grant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>APOLLO MEDICAL HOLDINGS, INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>PARTICIPANT</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;<FONT STYLE="font-size: 10pt"><U></U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; width: 5%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 43%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 43%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO RESTRICTED STOCK GRANT NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RESTRICTED STOCK AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>1.</B></TD><TD STYLE="text-align: justify"><B>General.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined
Terms</U>. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice, unless
the context clearly indicates otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Incorporation
of Terms of Plan</U>. The Restricted Shares are subject to the terms and conditions of the Plan which are incorporated herein by reference.
In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Grant.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Restricted Shares</U>. In consideration of Participant&rsquo;s employment with the Company or a Subsidiary and for other good and valuable
consideration, effective as of the Grant Date set forth in the Grant Notice (the &ldquo;<U>Grant Date</U>&rdquo;), the Company grants
to Participant the Restricted Shares, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as
provided in Article VIII of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Consideration
to the Company</U>. In consideration of the grant of the Restricted Shares by the Company, Participant agrees to render faithful and efficient
services to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in
the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its
Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason
whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary
and Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Vesting, Delivery, Restrictions, Etc.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Vesting</U>.
Subject to the terms and conditions of the Plan, the Restricted Shares shall vest at such times as are set forth in the Grant Notice;
provided, however, none of the Restricted Shares that have not become vested at the date of Participant&rsquo;s termination of employment
or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become
vested, except as may be otherwise provided by the Committee or as set forth in a written agreement between the Company and Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>.
Unless and until the Restricted Shares vest as set forth in the Grant Notice, Participant shall have no right to sell, assign, transfer,
pledge or otherwise encumber the Restricted Shares in any manner. Any purported attempt to sell, assign, transfer, pledge or otherwise
encumber any Restricted Shares under this Agreement shall be void and shall result in the forfeiture and cancellation of such Restricted
Shares. Upon Participant&rsquo;s termination of employment or service for any reason, with or without cause (including, but not limited
to, death, Disability or Retirement), any Restricted Shares that are unvested as of the date of such termination of employment or service
(and whose vesting is not accelerated pursuant to this Agreement or the Plan) shall be forfeited, and Participant shall have no further
rights with respect to such Restricted Shares under this Agreement or otherwise. The Restricted Shares shall be registered in book entry
in the name of Participant and shall include a legend indicating the possibility of cancellation and the restrictions on transfer of the
Restricted Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax
Withholding</U>. Subject to Section 3.4 below, the vesting of the Restricted Shares under this Agreement will result in Participant&rsquo;s
recognition of income for U.S. and federal tax purposes (and/or foreign tax purposes, if applicable) and shall be subject to tax and tax
withholdings as appropriate. The Company or any Subsidiary shall have the authority and the right to deduct or withhold, or require Participant
to remit to the Company, an amount sufficient to satisfy federal, state, local and foreign taxes (including Participant&rsquo;s FICA or
employment tax obligations) required by law to be withheld with respect to the vesting of the Restricted Shares. The Committee may, in
its sole discretion and in satisfaction of the foregoing requirement, withhold, or allow Participant to elect to have the Company withhold,
Shares otherwise issuable upon the vesting of any of the Restricted Shares (or allow the surrender of Shares). The number of Shares so
withheld or surrendered shall be limited to the number of Shares that have a Fair Market Value on the date of withholding or repurchase
no greater than the aggregate amount of such liabilities based on the minimum statutory withholding rates for federal, state, local and
foreign income tax and payroll tax purposes that are applicable to supplemental taxable income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
83(b) Election</U>. If Participant makes an election under Section 83(b) of the Code to be taxed with respect to the Restricted Shares
as of the date of transfer of the Restricted Shares rather than as of the date or dates upon which Participant would otherwise be taxable
under Section 83 of the Code, Participant shall be required to deliver a copy of such election to the Company promptly after filing such
election with the Internal Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
as Stockholder</U>. Upon issuance of the Restricted Shares and until the forfeiture or cancellation of the Restricted Shares, Participant
shall have, unless otherwise provided by the Committee, all the rights of a stockholder with respect to the Restricted Shares, subject
to the transferability and other restrictions set forth in this Agreement, including the right to receive all dividends and other distributions
paid or made with respect to the Restricted Shares; provided, however, that any extraordinary distributions with respect to the Company&rsquo;s
common stock received by Participant in the form of shares of such common stock shall be subject to the same vesting and other restrictions
as the Restricted Shares to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Other Provisions.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Administration</U>.
The Committee shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation
and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations
and determinations made by the Committee in good faith shall be final, binding and conclusive upon Participant, the Company and all other
interested persons. No member of the Committee or the Board, or any employee or officer of the Company, shall be personally liable for
any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Restricted Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments
Upon Specified Events</U>. The Committee may accelerate the vesting of the Restricted Shares in such circumstances as it, in its sole
discretion, may determine. In addition, upon the occurrence of certain events relating to the Company&rsquo;s common stock contemplated
by the Plan (including, without limitation, an extraordinary cash dividend on such Shares), the Committee shall make such adjustments
as the Committee deems appropriate to the Restricted Shares in order to preserve the benefits intended to be made available to Participant
under this Agreement. Participant acknowledges that the Restricted Shares are subject to adjustment, modification and termination in certain
events as provided in this Agreement and the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of
the Company (or any other person or entity as designated by the Committee) at the Company&rsquo;s principal office, and any notice to
be given to Participant shall be addressed to Participant at Participant&rsquo;s last address reflected on the Company&rsquo;s records.
By a notice given pursuant to this Section 4.3, either party may hereafter designate a different address for notices to be given to that
party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited
(with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Titles
and Headings</U>. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation,
validity, administration, enforcement and performance of the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conformity
to Laws</U>. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions
of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder,
state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be
administered, and the Restricted Shares are granted and shall be administered only in such a manner as to conform to such laws, rules
and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary
to conform to such laws, rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments,
Suspension and Termination</U>. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified,
suspended or terminated at any time or from time to time by the Committee or the Board; <U>provided</U>, <U>however</U>, that except as
may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect
the Restricted Shares in any material way without the prior written consent of Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall
inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section
3.2 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Not
a Contract of Employment</U>. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as
an employee or other service provider of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto) constitute the entire agreement of the parties
and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Data
Privacy</U>. In order to administer the Plan, the Company may process personal data about the Participant. Such data includes, but is
not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about
the Participant such as home address and business addresses and other contact information, and any other information that might be deemed
appropriate by the Company to facilitate the administration of the Plan. The Participant hereby gives explicit consent to the Company
to process any such personal data. The Participant also gives explicit consent to the Company to transfer any such personal data outside
the country in which the Participant works or is employed, including, if the Participant is not a U.S. resident, to the United States,
to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Electronic
Delivery</U>. The Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver,
including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual
and quarterly reports, and all other forms of communications (&ldquo;<U>Prospectus Information</U>&rdquo;) in connection with this and
any other Award made or offered under the Plan. The Participant has the right at any time to request that the Company deliver written
copies of any and all Prospectus Information at no charge. The Participant also hereby consents to any and all procedures the Company
has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that
the Company may elect to deliver and agrees that the Participant&rsquo;s electronic response or signature is the same as, and shall have
the same force and effect as, the Participant&rsquo;s manual signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[END OF DOCUMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>ameh-20231115.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaWGebOdzZR+uYkxtmB6bTka/yUnvEuscSpvacx24XcG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:AMEH="http://apollomed.net/20231115" elementFormDefault="qualified" targetNamespace="http://apollomed.net/20231115">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://apollomed.net/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ameh-20231115_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ameh-20231115_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>ameh-20231115_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>ameh-20231115_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://apollomed.net/role/Cover" xlink:href="ameh-20231115.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://apollomed.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139946939476080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 15,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">APOLLO MEDICAL HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4472349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1668 S. Garfield Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alhambra<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">282-0288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMEH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>tm2330755d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ameh-20231115.xsd" xlink:type="simple"/>
    <context id="AsOf2023-11-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-11-15</startDate>
            <endDate>2023-11-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2023-11-15">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-11-15">0001083446</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2023-11-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-11-15">2023-11-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-11-15">APOLLO MEDICAL HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-11-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-11-15">001-37392</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-11-15">95-4472349</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-11-15">1668 S. Garfield Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-11-15">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-11-15">Alhambra</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-11-15">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-11-15">91801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-11-15">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-11-15">282-0288</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-11-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-11-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-11-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-11-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2023-11-15">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-11-15">AMEH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-11-15">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-11-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " ",@G%7!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M (R"<5>!F#T:[0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( (R"<5>97)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ C()Q5[/
M;+18!   #A$  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( (R"<5>?H!OPL0(  .(,   -
M  "  9H,  !X;"]S='EL97,N>&UL4$L! A0#%     @ C()Q5Y>*NQS
M$P(   L              ( !=@\  %]R96QS+RYR96QS4$L! A0#%     @
MC()Q5ZK$(A8S 0  (@(   \              ( !7Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( (R"<5<D'INBK0   /@!   :              "
M ;\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (R"
M<5=ED'F2&0$  ,\#   3              "  :02  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  .X3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2330755d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://apollomed.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ameh-20231115.xsd</File>
    <File>ameh-20231115_lab.xml</File>
    <File>ameh-20231115_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2330755d1_8k.htm">tm2330755d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2330755d1_8k.htm": {
   "nsprefix": "AMEH",
   "nsuri": "http://apollomed.net/20231115",
   "dts": {
    "schema": {
     "local": [
      "ameh-20231115.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ameh-20231115_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ameh-20231115_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2330755d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://apollomed.net/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-11-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2330755d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-11-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2330755d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-23-119527-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-119527-xbrl.zip
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M-Q"02NZ7D:7 +$W4 -8+25OJ_'0#,-LZ]3!T07$"F(-/22J]7U(6CX12=3\
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MR1H#R0D[U:ZAZ+!L\F&1!H4*[ \<,ZH0=(AQG=$R3W&FTO.+3;[_*_G!TDI
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M[COG>BN:]KP@E9M2C1(\7Q4NRC5;5Z[ZAXW7JD(41ZJZK<[L4 >BWYQ1WX.
MRF,'(I3SOF,_F7!\)S?6SJ]6J_2C^$I*I_& @RRIZ9Q:*GV,MJX8_*3:\9\_
M2JJRL\O0%3&)RQD0!$!;/"PS?5YD6%_C0A0V\6_!]3="\HIM5X"'L.\YXQI0
M8?$&ZTHV4#^3M:S:11] F #)K"Q%4A1\#-:K+61T45WL?NBHS<.!];5CS#QT
M*8KURUNDEJZT$+;T">@/9.H(NQ#VN-3@V7O'&:(.,9T!GQEOY!-&I?01ZAHF
MN!MD,&3P(X8ZS-AS$#,LW_2P31R?F2/$("MBW9$8&0QP.L!1F2S)#2I$)^5<
M'^!0A.U1V-;E1P8'?!P/Q0R>M;/*ZMCXF6NXN8Q:-.S)E)XHKH5=WU1+2\J>
MOP.+.)O8;+(81O3?J>&!OO JC&\':3-+#A4*)S>#ZU[G[C[_ZE"^TG$<DV!;
MG.Z+!A&)9$CFE787E=V>66VX\YEG=$>OYG- (\PU2B1R([N_W&NC@EH,+(>;
M3&0KEN_ ;B@[J'YPB=1\+@,=5UR=^->BWL^B2H%%M6&]UT#@=N\$7#;X;3/9
MG 9N\=+K/%RW:LK2S6F6AM_,EB8$@L)*"F<-22G@M*)&;"EVEF%L285<1O;\
MUYC^,<84UF#.*>%K C\5+4Y-\<B&GG6[\]+9 \5_^':L/ SH\HUJ/BV_F7$!
MH6DM0NG"%4LIZ&EUH[/Y/%.3??\UMG^ZL;48\PE=:'+*M?OSX.M!VV^]K-;U
M"I.;H>C3&UZ>I L;VO,,+^C[3H:W](PV$@C+%)-02%+=V;.32!&^*$@Y@0TK
MS##?#O!S.Z@G2U9!HTFZ7D)K,"LY5HF\>: 6$\^*3$:$+QF(.M@K3>V*OW$I
MSV%J?:29F+$GS?SS3I1B#@NU1U;',3?8T[OK<B8OF40Q]PZ3"(\*"F&1T,.!
MJ0_Z!CR9^(,EG;MXCK3GONKR4FU8-?/F;4,%#G6DJ!UA#<G+\V']VYV^[5D_
M?KQR?V<:3:K*EV207=MSM/O7G"G[1TLGW.L/[%::[1S1,-JR+OQM=K/]2MG$
MD*2J_+WN-PB$&KU^$E,_NTAR4P83AECS#W2W\0_WYNI70ROVWG1J@;NZV0,+
M272 HX=@YQ0S'3](RT(GF-X3#QT?UU]P[G U&=@2@+5LG<?!!'5&2!.;&]#A
M'A8 (HXC3NT\& R!""&(YC!ZJ$>=@==?7X-XVN7;$9@AG70-6YXREU777#$,
M&:=*KO*EESS:X//9V165U[ SX $9N/QX.M\_DD&YVDFK";!"<:VO15ZE&4/E
M$?ID8 1N9DD;OTO<3%M%&#R3>$:/Y37C@D2!'$,JI!J_)G4]B)W5"=$<"BQU
MB239PK7FX\\+O:XXC9>=>GM.UOH$,<]-6#^KH%O=!+L-Q;T%QIKH!(R9G<<^
M6#@Q(1\$"[<=D1WZC(A>()E@?Y._RVJ(C%&^W\^%(W"9(XY\8 !J[BULF!JT
M4/)H,!@'?@/;&J\X8TU<%\,[\RN(=$QU)G<V]7FI:7X#CU/3:*J>>;DNAYJP
M&I&O+M']B#?5%T4CD3?9/_R@Q;31Q5G&4>W"N >?5XD O,0K(K)9%LR-N:(,
M5M0$#F^+ &I2E(@6(::+%'&<L]6%J2K$C-4_D:(!@?& CT>)?$3"&R:Q FGB
MFSJ+>DS#X$%1&!*%MS5,<]H%@:0[E.#[=(> !X%987. 1RS.Y.T$'G/&IR+!
M440-8M%3%'-4]U:C=HFO=;]($5Y9G7J&T2_2%5G'FBF*IZIS)*Z(6GFGVO*(
MA8J9G"HG+?ORA@9Q,?5\*LH/#8."'W<HX\M!';!CB![EZ54*XFZ:@9>/=MU%
M-==U#-L3!5UHF1W'UW9B,W[#R C5*.5K N_-#\RNKTWWSTQ(C*KG4G1 _ 2>
M!"8'RRWA<-)*=/=A:2O"&7_!8NI5X2VQ,NX[L)3&.;[!G_,CDVIN5S2+OY5=
M^69\35Q&ADX(CP],]-4QQ2(I3E)F8F/K8>@H1\OC48^P7,/ZC;#NN#QD$(7C
M)T'*%WV$3"$S\66]'B+[ 2?\W(35.XITTD6TA<BW8C&"K&7Q40&-P*\1ZE+'
M0AZPD7<1OWLBPN'WPWFC-+^&#^@>B- #>D"LLKY&Y%M(( H(@_!DA]R8D,&!
M]8E!$1E/)(-J$HQ  % GFPI3] O".H3G3O)4%[6XL" >33_X_+R\0?3U-2:R
M4& HW[O80O(C9S>!X$G8B2@80!,E$+89(E@+>@E"$AKXW3KPG,O*$7F?>!SC
M0@9=Q2A>7Q,D#S@K O'RR,[Q/3FX#X+EI]2$'DP=(PCRZ6,(*WF0)]*[XG:^
MN*%M;A0V!1D#PS0Y+[!N&7:X*]$9C>4H#!LF"X;,WU3S/$+"^$^H<>9W#M9K
MP 0/> ($%W.YK5PNAX*[X8(I1*Q)'&769&E/,!:T&]/U->"I3]#_YC*YG,(#
M;0EA"T+T1XCC";&YE GE)LCC;X-Q[FLD)@?\7,7<8'[G#CR&&*3S_3C1AMGZ
MVC@N#[1V:NCF6/T7JGU(AF.;(XYH8FZ#OA,[)#G)"L34(CHI8(2XIO4J8&Z"
M]H6ZSS$/^D3.1' G*'E$3'QL]OP@IP^NA6=/P *PT%!>X"IX^4R<_+3',Q&C
M1?83=4;\0< Z"[)6<?BS^Q+2?VM-YSX#=V A0#IA&C7<Z)'6:3W0'8#,TTK0
M47&K!["N0V1YR220GG(9@3PFRBC%-G:.P=T&B+]L2(D'6C62"U_7!V\B+N=+
M1@UPP,9<<:!6KA> IFN8W/LQM(>1O#S0L]1\/K=3+.K*+1DJN;22Z7O6.#[C
MM<4T(*%8 VZ18=_H&+S*(O]87U-R&64OBZMRE0 ,=9]23H(\^,PW7L8'AX.I
M&N,728$4<,P$9@A><'PGX0J%__\A-"UG^,M;\=#T8%R'$"^MR8B1BR.0XTHC
MQ?>Y_FE\H&)#WXQ.:[7(?K>30WROY=5GAQ3ES^D]E$PQ>1=E47$.)![(@+\8
M';O<[8D32<GXGW68J51:)NV-B6.?ICW8_8@QNH.U^QYU8(7F8G%H!?U1KS?K
M!P<+]HL[TZ66Q)+&LV?U-I?^-%.DGP_8@.>(,5GA7B[3%_'H*20K9<DKLCXT
M2?HRT]R,*M9BUBY),]2E:(;Z;IJQ'.$O8=8'02(K]T_/9 Q8ZU$BY;RQ2/R;
M3\K_-8YE11J27XJ&Y#^9ABQAUJ&&7$X*$U)9EJ8ER]:!!4(L)"[ARQ/&D^CK
MD&]1L:,!G )R01+\/H &]C 2%\*(&IHF>O$R.^+?7H$\W(,XEQ+$*X>Z'M1S
M@M14?LN%[*@'UQ-&&!YC]C+/.DPV:_Z)KS9/;SJI*]UT>M%^2!1];!/&%31_
MJBV8C[W;N-TZ/*U=75\N^8KK54T@W)S(9<0+#]%+=.5A@ ??H.-]E*G#..MK
M2??:;B4=(]!]<X0T[#.Q+V"P\"974?-!#+@H2H&BGM,A?6QVP_*O*.X%'7A)
MQ.<E-@$.^U[?H> )EUC^34QFIWA5*,?7VM\JPWW6RC<G3@!@W,-_2:FIIY>I
M9^2)"VY-G9\YOM,$IC>H7Q8XA,>VE3\7L8)?YEN)[-#MA)?Y/I'SSXL-PH1^
M(=+]4>7I>_R>FE1A\:2R+(NN^J"MC%\K=HRM50CS31HHOKQGKT/%5[N($].5
M9Y^&?F9>O8B$&(.VT$FFD>$_SS-?,R%A=2==[QND.W.-$Q4ER'-*F/B:E]5'
M7K]-4)3?#5)&5D'BFI#?)D;ZV( ER[]!2IPMYE]85GWF]U65]F_%23UQ1TCD
M>Z[(M^'!E<Z.>O>UB^S%<?:'?F<?[?]=*G4.S19MM>Y)7QF-K.]Z4[>\,K/+
M/\EI^^Y"LT[]XE'C[\LCA>+]OG56VCFJU3W?/[DX[ ]K;.3?G1Q=;)?R9]>]
MQ])WM_SC[+S.SK>;UGV[X3#+4J]MOY8][9_K/XK?3LR3^Y,?H^+!_>%?V^K1
M7[1DZ3M-Q;?V3VNESM_LL/N@'K8&V?V"?O1X8ES^I>P E![)>6<[1YWA7^?%
MVJ&AN3MG_;[-+O*-W/?^WU<7/X]@!J[]>#,L#\O._H_OC0YN%Z^[[M=R\T9]
MZ'\[J'WY(EGQ?U!+ P04    " ",@G%79\DS=K='   >IP$ %@   '1M,C,S
M,#<U-60Q7V5X,3 M,2YH=&WM?5MSVT:V[CNK^!]PILZ>$JLHQ9?8,XES4B5;
MRHRJ',?;=C)[ZM1Y  E00@P"'%PD:W[]6=?NU;B0DI5$\MZ<AXE%@D"C>_7J
M=?G6M[[[^X<?7W\_G7SW]]/C$_AOA/_[[L/9A]>GWW_W%?\7OOU*OO[NY4\G
M_XS>?_CGZ]/_\Z=5633?1H\?;9KH0[9.Z^A->A6]*]=Q,></YM'[M,I6?X(?
MPD_?ZN^:]%-S&.?9>?%M5&7G%\V+:!U7YQG\^>A/WW_WPT]O/MA''-;9OU-^
M#GS[\OO33Q?9(FO@@Z/'WWWU$H:)OX#_O.T\Q]WT1=1[Y*[G_+E8U)L7H[>^
MZ:N;-X-+.P-9ID635O)95B0IWO-15MQ@#H[?_O3Z]4_3R8^G)V>OCE]'?__I
M]<G9F[^]GT=G;UX=;9V5^Q[ZZ8]O7__TSQ]/WWR83L[>G/S\ZA3_'1W_X_C=
M2?3V]?&;!SUZE8N=0UR4>?+9XVRJN*A79;7^-FHWF[1:QG7ZV[S"\;L/9Z]>
MG\+4'WWW\AV,_&U;;<HZ_3+?YH_8I;^V=9.MKKN#.WJV>W@?+K(:9CB/B^@B
MKJ-%FA916C?Q(L_JBS2)TM4J73;991K!M^4J>E->INM%6D6/G\VC)X^>/)U'
MS44:)7&3XM?Q9E.5EW&._\;/Z<:+:_KWRS*NDJ/H@WS\YZK^5UN^J*,-+V^$
M VG**"TNXF*9TD]>E>M-7%R[2^-%EF<-W*Z,X@;6;-E$<9%$ZQ)&B". 5\\N
MLZ2-\SJZNH"+JC1*/VW@#>!5X$?K^"-<M-Z451,73;2$V:BR1=MD95'C]^:9
MTPG>.6OJZ'V[J+,DBZL,E@?>!=\0_B[.H[I=7H3/S)J+*/U7"V,\7( (P0T*
M%!R:ORMX_1JG$7[1+M,U?$X/)<&"#_&?ZTU>7N,W?"L8SW0B XK**HK]8*[]
M3,+,X<]36'=ZRP6^--RJB595N8[JIEQ^O(#= 4]QZP.37K<X!W#]F[A.XG]%
M[_&ZZ,>X^I@VT;LV3Z-GSY\^.UC.#KZ>P6S T*,-/LV_?_IIF;<UO%Q^'<'F
MB?Z<)[A.YBW\J_ZYHN]T&@[P_;*"9GR=Q@7>#L5K]U!F1S E\29K0/C_C2^<
M5NLZ:GFRO=#ATB?I*BOX\^.JR99YRKOQOT"S/-0->2-]\4!UG=?<JKI/X889
M;]HO\Y4>N/KF^<U!2YP9-41J3[X1A7 .,X1*\)BW7UN@-M#-,@=-MO@5M*3J
MP#Q;P_YBM9BD]1*4)/SV(JW2K-AOG=]YZ^C>.4[669'5\$Q<"#KH3M(\/:<_
MO\RW?."[Z2EX:[T+5O$ZRZ^_W>4_\JO=Y/_U]7_^/ESA[[[Z^7LXV^RI'LL%
ML/$2-:/ '(#-V:0I&P!D5<%\7$=56J?5)6UX,%O2'*PQM!K8$(O;YJ*LT':2
M#]QMT*[ GY,Q5=-W9EQE-9U86PZ/>35&\EQMM_J%6 5I,H\NRJOT,JW0,(P;
MNAANC1+<@/456H-X,H,15J1\@=H\[KU%]'D 8J;6%_C@HFQ0K24I&!>)F#5^
MCOCF;9&G=<U6&@^!5:.].H9W_S68&%"DZ28EL8E.L@J&5E;U4: XP4[5^;C*
M8#"+\)X'\2R<XCD8HQD,@H<.5R_!I*LR-%G0.*S0?H*G#SYYCE-]L)CU1^HL
M0V<>#P_]P6ZW!Z\-GORAVN M[)NJ=MLMV(2D&VB_!Q^3S^:W-NS\)$5[&*Q>
M$3DU$")K'X!DI.B2L$S/V3A0"<=SQGF +.EL8N,7L%F3C'<2#%-_W[$>S$7X
M&VM,& M]Z'5@<"6]4ZBRFA+&@:X;;A^WD]'QTP_UM>4Q7?,&52*>6)L*_ GO
M(A1B#T7'YU4J#AE^B.YE4FZ:>13#APE]5L'.BG/1058_P3Q6X*'@-+:@ '.8
M>[[+!OW3;)FRS]>0KD*5?IG5,+F@%, WS%MTI.81^*"DTFBNR(N;BR*$88@*
M! 6S3),6U/QT0HY= R)'<X[_M0Y@6M1PF>I?XZ'2F5(,"07</8,%D!4D@1"7
M#!6XB 9\VW%YIY-PJJ,#\U*HSLNV,0( $PH3"?YQ1;,-4T#WEZ.B<V^P,BK<
MNQW'/!PIB?*FH5T#C^?E[(R);GY!!UT-_T'YPKD&8;C,RK8&Y<MA#W);@X/6
M^=WP'^]YDTK.5O8&^MOY=(*WOXA!:, (*^)H!3(1@1&5E0G.9E$6A]X_GK.X
MX?C<M/N-U7T/7CSO4H/X@TQG,%,P&1?P+2H$=/)5FB6>LBV\,/Z6LZ$-BH;"
MLJSP:$'O&O[#LAZO%QF(?Y.EI XV&SS1UEE=XW;D4 K\IBR668ZB"O^JT:R!
MO]- *>@P.MLRV$%@+<"Q#B.DB_'<!8G Z ]M6S68PFU. 1V>U8'7<@?H5C5"
MM@.,%6-"=0GOD63@&:7..%=38 6_S^F3!0HS[J*"C250[S0=%_$E?5Q%RSR&
MS0'_QI<F%06J=W1"]D?Y^/#TF?_K\##Z(4OSY-OH;7P.?LM[T#<@:#C4Z/!0
M\D??G9S]$N9@#IMR Y<\V;A4S^&B;)H2G*#G^-FBK$ 8W&<O\WCY,7H,HP11
MR!(8P(?CEZ]/HU>GKU^_/3[!3,?_^=.C/]'?[]\>O]*_Y9ERMV69Y_&FAK'I
MOUZ &"7-!4[6H_]X$?7C^Q_>Z3TN43TNXUSG!UX@G+ \7=$O3O07<NNG3__#
MK]B'DZ$KOOZ/(8</;F:F5R?V1?3A>@,#/*[B1;9\$;V!0Y,G_TWY(OJ)SJ_Z
MV^CO60(KADL@CS:W^DKOA5^/C>EI9TR2)+,O\M6'=_A_N!+P7UCC@>5>5&G\
M\7"1@B<#P]R0C%@1>#X@ 2@6\/+]M)V5_;?A(^WKX62P\'UQF_:!1A)\O.27
MH_Z55RG*QK=PVE;K.,>LV#M*$=.;<G#Y^#+.<K3#R*7EH^'+G(K[U[U;A_?U
M'QQ4>=-B?HH,PO<7<&37[#N]]SY*G.#KD%W!)WR0'/CE[.Q,S#+U?,@C _LJ
MN.[L%S;1U_&G;-VNHX*>&[G'DEDWG:#%1(&*'#P%#./8S,NPG>?"!,\>/9H_
M>O1(;GBD-P:SJDU[5BZ;9F17D=G.WA-F2,"Y0#M=?L8WF>O-8#C+"TI5E6QU
ME)L4;T:I%[2S05V"-W&M@WBP<O;@M\&36TCSS]_3=$\G[]+E]1)\RG.6XK,5
M69)B%&[BBM=:'9_TTR:CQ25;@AP"$%O0.JL4W<IYM,34:H[_@C6MT&&L\ ]8
MXR5Y9?A%VC0Y)\U 1UU$& %4JSA-G%.'HH(21;E:)_2\)=J"TG$B8<ORTL8O
M>:1H+,_1K <#/@<KAASB!;@(:_+3XO,8GH]Q-:NFU83OB#Y,"[KD''-P@NUW
MW &\//I%"XI$HF<IW[$'T308[L#?SKJN)@4(W\:X[;.-[-D:+JU7UQP9\:/'
ME&NUS&H:OFXJ]%5Y>MP2@6;YBMU7N1%'2/U]FO@333)F;,E+6(#LQ3X^"N^V
M4456R(P8MUM?'QR3F)*?'6^6(P>Z#K//6XB>XN*X"+M6FYA=3'CK$W3E,8)R
M"M)U&><485'!XMCOKVUA@K_DB;8-K =[3O(<'_-=EBVZ@SBJFH60WI=C#-,)
M""^.KZ&[OY>P,IQ 7[C:>J"6AS/"?I&4%9M68O+3(2K&%GCIZ3)C*7Z'MMG>
MUOH]A.G9T>-;'3)_2XNTBG.3>>J'>S@HI6L*'XXN*:JDP7CSENQR-R <I#WA
M8114\4%MO+9G:)D#!LZQ"QGK5O%S!MYXK'HZL4J91^YU_.K&CSJ*CL>'0:^'
M.: FYY>SA\T!O'^))]=TPJ$CO9*#O#H64H(C#Z 33</]3O7K6=!N\)[FG<P[
MTFLC4,HFX+9,9Q2O236[M:+U6+=YDVWR:]3E?'.,W?FXKSSSASBK%.[S2YRW
M-)BR4.4NEJF S*83/^1+,0/<)WS@PG3I3U=;YT=/QYY,=8]:SJ8,WPJL-+H7
MF%HZCB1(BN!<6Z&W"56T!33^V]]\B%6K4PX3P[E*BR+GIS-T"!<&Y_5"XI8N
M@]1<E8,97;JSWU-HKW#R5G=C)_KZA1^>]ZF._]@,XJE('UACN W&DH:L=#3%
M-[1_;J'>-+?=N0,^8SJ1+#VEX4'*"XIJ;MGT+'Y_HQ/G1""E^(F,8\OALY?1
MSY;1I[<R&4[: *UR:L1DR_*XY(@]733EU]![4YH&; 70N-DJ\VC.CC*:.Z2)
MTYOLGXJ7==.QH&CB:40(TB*Z3F-$>;PI&]3\SO_  6"@^+SD)(T#E9ACCH[H
M*]IVH:\UUU=(+]$?HN&*B.<Q>"^+ML9D,=PL=NB3V[V)(DTZ9_AT<H/?PFD%
M,TEU*GQ6'WMSYW5\13YA>)@'KR:H%#F#\$21S>X"2G .59@=<;\U]I0U<Y(V
MU4-2#1-P[C+R+*N8EF%3P@^OK9>[P/P+QB$XM5K/^!@4!'(.[WS8;@1S#):<
M2R22Q\I I 'L$259?4RC3I=M14G-WNO;M;J9A@+G5.-Z<=O !J?D#>:./TGF
M'LRG+/>6#LD+K-+31R@@L$%6FM9$CUJ>BWC W"TDQ3]H:@[]W."@9$)\:GA.
MB.[1]1W$<\&$%:4(,[\+RQX,'_.\(M3I=>F"I[RO>*(.)&A57X!1F58:-X6!
M9"LC&C.'6//2LE?_OW-F],D^,_I'9T9QQI_L<Z#[[;G#.OOZ5M:9>@!BG=TH
M$A=)BLKYKG@62(2<;* P)HYZ'"$PQ^?P&@A+O:H0Y(IG0Z.^@]R)CHQX.L%0
MW( ;*IA9+ 8B%T+'D<.17)5%MA08G3/WJK(]IT.Z+!!FA^5(#=U['6>%#W=C
MK)T&!TXX+( [W%P8Q>3&NH&4W4<-H@G/4THHH,W0BYUK^!M>?=7F>2>L(OX1
MS<EPY &_X/GP-J"-+!Q%/Q?B4'4GU%FB_F"OY[M,28U>&!/.2P+!O:-5)0AN
M-$QYG.Q7]MU&_S!9S4V<)<X0-HBI(90K \70";!A_(XQT/$'OB4CV">K2#93
MEVYX058JKC\ENU">;YX. H'Q$#_-D.DZ"8@+(U_G,)AS--GZ+JU$=@BB:78&
MCI!Q>_1V[@;AA,+@ESAXF!=Z/5IV=XFUAJ^#E%&8 :-9ZX3Z*K^;HD55?H03
M-ZX)D@?S7X'_?<[FLHM[-@0GW*!0-8/^0CV#T28S3IF9:)0N]!JV#-CIIIQ(
MEM:[5\L\;C%K"0LZ9\@[Y\I@$EZ0OY'.=-@H*=<L[W+G7@U N#4$M^<%\"@Z
M1A@?:H-:H;KLE9*9+;A2'3WJMA5<H&^4ND@+2BSM<Y/VZN_W>:!"V7A>XMNJ
M=#L08Q]&0/5;DKR7]3#NTQ=N^3[0/(_/;&DUUCO0"K"2*/ND0U]$W4] +V?[
MO-;O(DK/?[>\5G<1YY&<RV19XWYSN?S^I1*U&,AY]6HB.J4ZTXF[?Y6Z)PBT
M0V$=%!P3+<#G2%:Q(M#S5H[\" ^LE!Q]E(XVC^4"E_'III7HN72>D26"\)"6
MLR7FH3-,TY@$65^K:K"N'@G6$60:C0K&.F!4CYV.;AC#G^\P,S+/J&I]!$/B
M/&/)$L]9P!84O0:#ID-TR' VI"L,FNJB+;UUG0/3U2PZV+6-Q@S-#)OI3-I*
M0XS&O.F_/<71Y/7G/>O( 4M\NF8LY.]3/CBHGHW573N/?PLK?]AVI?Q 3P7B
ME8-ZD>]^FU(A)&>(M7S?Y8@?K(IZ\!KT=O"SWE8@7?I@7^_^9O_Q[L&!/7N[
M%(N@IFHYOXSR!K<CM/%!?_;VF\NU&+0 'RWP2ZR;(5<IT:>0B]9+>)MSP*=<
ML+PIJ.X=UJ;;T\G\2V,NDTF,CQL;(.>K5VF%[A?HB>D$E0/, D7T-Y)348TK
M1TIW6CKG0#OF1,O@:^]-*US!C BN2_ 72AX#?D#%OBX!SUQBGH]GM.[3JL&L
M"?U-J5#*_0^][]S#V@;NX5:WHTGK>!V>G37EFLAB1!^0B7/,:>0^JH/G#<K3
M"!8"!I/*:]^+:KC!WGO8BF%Q.\5 RS&=O**Z2/1&%=S^P3B73 5 MIW?HT&^
M+=V4=48!*O3%RZM^,:#&^& ;8  MG?$>)6E8FJ=/)^*7PKU40+SG.B!+G>!9
M%,M--UC[C 9A60F1SP).^X][J?K,P_YV.?T1N_<(A>O!ON3#WMFW//+?$^@>
M#\2M/JL>K%PN[7XSJ+79=:'3HEPNVXH/2HQP^K@7UG:4!?@=UP,A,(J8C]P6
MS]I(_0J$8J=QPF4N?$K/J>85QEPD.'APCN*:"Y3["LE5WU+@GP[G3'Y<<.4R
MI<>IF!F),W(.=BJ\F^?PZT??'.^UQ?#@;I  ?KI/ -]' OCI/@'\/WMK_O;F
M(1,]2E)/S,/CP/XCG7T17V)DCN6GYL2>)8KLVOQBTG5 S<.A'G&MR%'SF"8-
M9%:V&!(4?7B,#7EN=-<O6KD_T*B_R7)HFN,GLLUIV@]?4EDHEV"]B&!7GYV<
MOCF)3O_SY[-?CE^?OOGP_LM\[0=NO?_EELF.G[A$I+]FO/G'5E1CULH,"5O:
M!IIL9)L3S2GE.:_)]O-I<%\,R/7.N+\O,?5-F_OJ HE2./]*:8T%.J=@(](Y
MARQ' 6QA80N1AXI"YBXDA=XKAJ!1++IJR<:JMS)0[9J;,* S=QB#7EBGDN?V
MTMXNN\V RWZXR2,U@AIUO)"L_;I;,3*4PABHDAKA[)I.&-@__.*&DXH+C(,Z
MUCEF(7!'$C[VO(SS@WK6 >\$*_C67/ZJRHBL:#9W0:DP7,5%+AK$\X-6071Q
MKYMC0_;QZL]60;?+%FC$>CHQA;YJ>SA6JQ%?$N1W1!P#GS?N&#$2LC)Y5*YR
M&QP+"Q?8.T$(=[ \V:&TM=ZJ:PK=I!3R:'@8@5Y94@5^DQ/L: G6D#"_$:1H
MR87.BA(SKSY4H>^,*\SK]>/"-JF(!(.WB0MKN?Y8.=S@'+I@>&= $OY&U<2:
MV>;_!F!?O<SFZ:=ENB$ZL &LVPCT9S#9:1/.O0J3P7?J%]_+\%A@RB+W2TL$
M"3VH3HBF\L%9T7F4U7"ST:L]I<H%KJ04)H$J]7GU+US5/5!+T1K(GI99V6/
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M0VXP#RA./V&(M,ZO?="STX>W%]]R41,!U73;CA?E2.$='BN"TTI:!L.QV[U
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M!^ :WPT,Y 1\G>$<UCP [3J311?=LU?7G>S[/#KX-$/S*VF7Z1ANLE;<I!7
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MRYC4P^!V,EHPK,LR8ZN=2F7F?I-RU3IOW['A*;E4&+WTL;9@B#[I-1#<"[*
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MBC#QE^GDME;$03P[>#(#CQ@)C0UA"5D7"9S9U])GB H9LT^':UC3"\T%V8*
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M XIH6X$I"_^R OM$&:%9$5)'G1;\T\$JPY: KG4.\U5FU<W6X\':\O?O:MP
M&?#-'AEP'\B ;_;(@/WVW$D']&@$Q7?9;>UXQJ'"3N<%FPF1-L>(15=T,!<,
MLR>6,[\E!= O8?"<:V8S#KN"\$DEEPEGC5R9-=>&$,CP#7/I,"I\/*\ZB2MG
MFN,8U0HS5$+P=8HGS)+!I1*G&QBGR8Q=4.(YA9.6 @!):DB,!GX9:^*('UZT
MV(D9+L=D_?Y4N8/8#M!884$.E8M2[%?[ =8&>*JI-"ESXX FIHV:JS0-;9Q!
M7*/S);0OH(]LZCWBT'WH^L8'O>S5;*Q2Z"+6[(V$AHT<<UFL(\W@7>8IFSR8
M M-&K6_RMN55$IDO/QSM9SD"%/=-M[F6Y@>FF*HHEXI7><)M-*2XR9=O:<.U
MU#9"G5D:078;+I$"M3AO4;E+Q\,M1%2CB\/D!=I3#PL?-QHVH-UJ?!3.*.
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M]NF$^T@G/'ZTSR?L-^C.DV:@0 5.FG>F))XL+.XD\%+JP'TO 2G3[Y!%J/'
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M+W\Z^>?W^(^_?_CQ]??_'U!+ P04    " ",@G%72[BP#/<<  "_I   %@
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MD2 J,B!NADS'H#0@-*$*+# I( GV< ;8D=[F66^!A0'^GNH\5TILPAR>&<@
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M[(J3VH?QH..V@EP/; %CJ'%^,!6):Y1;C&3"S-CR)N2%,[14\\;$&.)0+/:
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M."VH\"DY\P@YN!OTV%AA;D $)A]I?CT1)6!E] @"H(8ZQC4E%,0FP%8FZRS
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MU68$R,* W5$L%'--F0_?;6'-=:VERK/Q IZBEOI09;VR7RQRV_)7$?PJH77
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M8RKF@VX3%"P5[WQ(-)\01I#S)?80/U)D=F_#0 0=[6"\T7=*4EC7V!+T"RD
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M%@  =&TR,S,P-S4U9#%?.&LN:'1M4$L! A0#%     @ C()Q5V?),W:W1P
M'J<! !8              ( !E"H  '1M,C,S,#<U-60Q7V5X,3 M,2YH=&U0
M2P$"% ,4    " ",@G%72[BP#/<<  "_I   %@              @ %_<@
M=&TR,S,P-S4U9#%?97@Q,"TR+FAT;5!+ 0(4 Q0    ( (R"<5>N&>^D3!@
M *F"   6              "  :J/  !T;3(S,S W-35D,5]E>#$P+3,N:'1M
64$L%!@     '  < T0$  "JH      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
